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SUMMARY
DNA methylase catalyses the transfer of a methyl group 
from S-Adenosyl-L-Methionine to the 5 position on deoxycytidine 
residues in CpG dinucleotides of DNA. DNA methylase has been 
purified 2000 fold from mouse Krebs II ascites tumour cells by 
modification of the original purification procedure of Turnbull 
and Adams (1976). The purified enzyme has been used to raise 
polyclonal antibodies in rabbits in order to study the enzyme 
in vitro.
Partial proteolysis of DNA methylase using trypsin 
results in an "activated" form of the enzyme which shows an 
increased specific activity with both native and denatured DNA 
as the substrate. Western blots of trypsin-treated enzymes have 
shown that proteolysis results in a loss of the 190 kD and 160 kD 
forms of DNA methylase, with the progressive appearance of lower 
molecular weight, immunologically cross reacting polypeptides.
In vitro as in vivo, DNA methylase acts almost exclusively at CpG 
dinucleotides. The increased activity of the trypsin-treated enzyme 
may be due to a loss of CpG specificity. Another possibility is 
that trypsin "activates" DNA methylase by releasing the enzyme 
from the constraint of acting only at hemi-methylated sites on 
DNA. Partial proteolysis, by leading to an increase in de novo 
methylation activity by the enzyme, may reflect changes occurring 
in vivo in embryonic cells.
- xiv -
Purified DNA methylase has also been used to immunize 
rats, for the purpose of generating monoclonal antibodies by the 
fusion of rat spleen lymphocytes with myeloma cells. From the 
positive hybridoma clones obtained, 6 were selected for further 
study. Purified monoclonal immunoglobulins were tested for their 
ability to:
(a) Inactivate DNA methylase in a standard assay.
(b) Precipitate DNA methylase from solution.
(c) Detect DNA methylase on Western blots.
Preliminary results using single clones failed to 
detect DNA methylase by these criteria, although the subsequent 
use of pooled immunoglobulin fractions has resulted in the 
complete inactivation of enzyme activity in vitro.
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CHAPTER 1 : INTRODUCTION
1.1 Overview of DNA Methylation
1.1.1 The Occurrence of Methylated Bases in DNA
The existence of minor methylated bases in DNA has been 
recognised since 1925, when 5-methyl cytosine (5-mC) was reported 
as a constituent of the nucleic acid of Mycobacterium tuberculosis 
(Johnson and Coghill, 1925). In 1950 5-mC was identified as a 
minor base component in the DNA of mammals, fish, plants and 
some insects (Wyatt, 1950). 6-methyl adenine was identified in 
bacterial DNA by Dunn and Smith (1958).
The product of cytosine methylation is 5-methyl cytosine, 
where a methyl group from S-adenosyl-L-methionine is transferred to 
the 5 position on the pyrimidine ring. In some bacterial DNA, N4 
methyl cytosine has also been detected.
6-methyl amino purine (6-methyladenine) is the product of 
adenine methylation. The methyl group, again donated by S-adenosyl- 
L-methionine, is attached to the amino group at the 6 position in 
the purine ring.
1.1.2 Distribution of Methylated Bases in DNA
The distribution of methylated bases in DNA varies greatly 
between species; 5-mC and 6-methyl adenine are entirely absent from 
the genomic DNA of some species, whilst in others only one modified 
base is present. In prokaryotes and lower eukaryotes 6-methyl 
adenine is more commonly found, while 5-mC is more prevalent in 
higher eukaryotes. With rare exceptions, 5-mC is the only modified 
base present in animal cell DNA.
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1.1.3 The Effect of Methylation on DNA Structure
Methylation of cytosine residues in DNA introduces a methyl 
group into the major groove of the DNA helix. This modification 
has no effect on the base pairing with guanine residues. 5-mC is 
a stable component in the DNA structure although occasionally in 
vivo it may be subject to deamination to thymine (see next section). 
Methylation may, however, have a considerable effect on the physical 
structure of DNA: the substitution of a methyl group at the 5-position
on cytosines results in an increase in the hydrophobic interactions 
involved in base stacking, thus increasing the stability of the helix. 
This has the effect of raising the melting temperature of the polymer 
and lowering its buoyant density (Gill et_al, 1974; Wagner and 
Capesius, 1981).
In conditions of high salt, the secondary structure of DNA 
is known to undergo a conformational change in regions of alternating 
purines and pyrimidines, converting from the right-handed B form of 
DNA to a left-handed helix designated Z-DNA. Transition from the B 
form to Z-DNA is also favoured under physiological salt conditions 
when the DNA sequence consists of alternating 5-mC and Guanine (Behe 
and Felsenfeld, 1981; Pohl and Jovin, 1972). The protrusion of 
methyl groups into the major groove results in some destabilisation 
of the B-helix. In Z-DNA the major groove is filled with cytosine 
and guanine Ny,Cg atoms, and the same methyl groups form a 
stabilising hydrophobic region. Although the presence of only four 
alternating 5-mCpG dinucleotides may be sufficient to effect the 
transition to Z-DNA, the low frequency of CpG dinucleotides in 
vertebrate DNA has led to some doubt about the likelihood of such
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an event occurring to a significant degree in vivo.
The use of Z-specific antibodies has indicated the
presence of Z-DNA in a variety of species, from protozoa to mammals;
however, the very low incidence of 5-mC in some of these species
(e.g. insects) casts some doubt on the importance of methyl 
cytosine in the transition to Z-DNA.
Conversion of short stretches of DNA to the Z-form may 
have a considerable effect on chromatin structure; the change from 
a right-handed helix to the left-handed form is- thought to relax 
chromatin structure over as much as 100 Kb pairs of the immediate 
sequence (Adams and Burdon, 1985). In addition, Nickel et al (1982) 
have shown that nucleosomes do not form on Z-DNA, thus Z-DNA may 
constitute a sequence open to the regulatory influences of specific 
proteins involved in the control of transcription.
Although runs of purines and pyrimidines have been found 
in vertebrate DNA, they rarely occur in the promotor region of 
genes where they might be expected if they have a function in the 
control of transcription. It seems unlikely that methylation of 
cytosines in such sequences is sufficient to effect the transition 
of B-DNA to the Z configuration; more likely is the situation 
whereby regulatory molecules interact with one or more methyl 
cytosine residues to stabilise the region in the Z-form (Adams 
and Burdon, 1985).
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1.2 DNA Methylation in Eukaryotes
1.2.1 Tissue and Species Distribution of
5-Methyl Cytosine in Eukaryotes
The genomic content of 5-methyl cytosine varies 
considerably between species (Vanyushin et al, 1970; Kappler et al, 
1971) ranging from almost undetectable levels in yeast and insects 
to between 1% and 5% in mammalian cells and up to 30% 5-methyl 
cytosine : cytosine in plants.
The variation in 5-methyl cytosine levels in DNA also 
extends to different tissues of the same specie's (Vanyushin et al, 
1970; Kappler et al. 1971). Differences in the total level of 
5-methyl cytosine in the DNA from various tissues in rat, mouse, 
human, bull and monkey have been reported (Vanyushin et al, 1973; 
Gama-Sosa et al, 1983; Erlich et al, 1982; Vanyushin et al, 1970).
Studies have shown that specific genes may be under- 
methylated in certain somatic tissues as compared with germ line 
DNA (Waalwijk et al, 1978; Mandel et al, 1979). This might occur 
during differentiation by the replication of DNA in the absence of 
methylation (Razin et al, 1980). Stein et al (1983) demonstrated 
that several housekeeping genes have a fixed methylation pattern 
in all somatic and germ line DNA, characterised by a hypomethylated 
51 region and a methylated 31 end. This pattern may direct the 
organisation of an active chromatin structure, allowing immediate 
expression of these genes, even during the early stages of 
development. In contrast, tissue specific genes, which are fully 
methylated in sperm DNA would remain in an inactive conformation.
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Hyporaethylation of sperm DNA has been shown in several 
species; sperm DNA from bulls, sheep and pigs is found to be under 
methylated by about one-third in comparison with DNA from other 
species (Vanyushin et al, 1 9 7 0 ) .  This largely 'reflects ( methylation 
of satellite DNA sequences: most satellite DNA in the sperm of
cattle and mice is hypomethylated in comparison with DNA from 
somatic tissues (Adams et al, 1 9 8 3 ) .  Satellite DNAs are often 
associated with the heterochromatin present around the centromeres 
of chromosomes (Kumit et al, 1973) and may have some structural 
function in the chromosome. Satellite DNA in germ cells may 
be involved in the segregation of chromosomes and in meiotic 
recombination events (Lewin, 1983; Kaput et al, 1979; Bostock, 
1 9 7 9 ) .  Methylation of these sequences may inhibit such 
recombination events in somatic cells (Adams et al, 1 9 8 3 ) .
In many species, under-methylation of sperm DNA is slight, 
perhaps indicating differences in the process of spermatogenesis 
in different animals (Ehrlich et al, 1 9 8 2 ). Ageing of cells also 
appears to influence the level of 5-mC in salmon DNA (Berdyshev,
1967) and in cattle (Romanov and Vanyushin, 1 9 8 0 ) .
The variation observed in the 5-mC content of DNA in 
mammalian tissues raises questions about the role of DNA methylation, 
in particular, the significance of 5-mC in the control of gene 
expression. It is possible that tissue specific methylation 
patterns are a secondary consequence of changes in gene expression.
Possible functions of DNA methylation and its role in
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differentiation will be discussed in Section 1.2.4.
1.2.2 Sequence Specificity of DNA Methylation
Methylation of eukaryotic DNA occurs predominantly on the 
cytosine residue in the dinucleotide sequence CpG (Sinsheimer, 1954; 
Doskocil et al, 1962; Grippo et al, 1968). Between 502 and 902 of 
cytosines in this sequence are methylated in eukaryotes (Gruenbaum 
et al, 1982).
It has been known for some time that CpG is deficient in 
vertebrate genomes (Josse et al, 1961) occurring at only 252 of the 
expected frequency predicted from base composition analysis whereby 
pCG = [pC x pG]. In addition, the genomic distribution of CpG is 
non-random: approximately 1-22 of the vertebrate genome consists of
unmethylated CpG rich stretches of DNA of about 1Kb in length. These 
localised sequences account for approximately 502 of all unmethylated 
CpG dinucleotides in the genome (Bird et al, 1985). This phenomenon 
is discussed further in Section 1.2.3. CpG suppression is less 
apparent in coding DNA sequences: gene sequences contain a
significantly higher level of CpG than the rest of the genome, with 
51 flanking regions enriched for CpG, while 31 flanking regions are 
often depleted (McClelland et al, 1982; Gerber-Huber et al, 1983).
Since CpG dinucleotides are deficient only in genomes 
which are partially or highly methylated (i.e. in the genomes of 
vertebrates and some invertebrates) (Salser, 1977) the phenomenon 
of CpG suppression may result from selection against 5-mC, possibly 
due to steric hindrance at the DNA helix level. Methylation of 
cytosine residues introduces a methyl group into the major groove
-  6 -
of the DNA helix which may result in structural changes in both 
DNA and chromatin (Nussiner, 1984). Mutation of 5-mC to thymine 
could also account for the loss of CpG dinucleotides from the 
genome: Deamination of 5-mC to thymine in vitro occurs only
in single stranded regions of. DNA, where the NH£ group is not 
involved in hydrogen bonding (Adams and Eason, 1984) . If this 
situation reflects events in vivo then deamination may occur 
less frequently in regions of high G+C content where "breathing" 
of DNA is restricted due to increased helical stablity.
If the CpG deficiency observed in vertebrates is due to 
the progressive mutation of 5-raC to thymine throughout evolution, the 
remaining CpG dinucleotide residues are presumably of importance in 
the DNA function. They may have been preserved as a result of their 
failure to be methylated (see below). The reason as to why specific 
genes retain very highly localised levels of unmethylated CpG 
dinucleotides, and the relationship between the methylation status 
and the activation state of a gene remains unclear.
Selective methylation of cytosines may influence the inter­
action of DNA sequences with regulatory molecules. The presence or 
.absence of a methyl group protruding into the major groove of the 
helix is known to have a decisive effect on the binding of the lac 
repressor in E coli. The A:T nucleotide pair at position 13 of the 
binding site sequence is crucial: Mutation of T to U or C at this
site substantially reduces the affinity of the lac repressor for its 
target sequence. When 5-mC was substituted for C at position 13, the 
stability of the repressor-operator complex was equivalent to that of
- 7 -
the wild-type, indicating that the presence of a methyl group at this 
position is essential for recognition of the operator sequence by 
the lac repressor protein (Fisher and Carruthers, 1979). Changes in 
the major groove are also known to affect the binding of restriction 
methylases, histones and hormone receptors to DNA (Lin et al, 1976; 
Yuan et al, 1970; Kallos et al, 1978).
Further, direct evidence that methylation can alter the 
binding of proteins to DNA comes from the footprinting studies by 
Becker et al (1987) which demonstrated that in vitro methylation of 
cloned DNA from the tyrosine aminotransferase gene of rat hepatoma 
cells completely abolishes the binding of at least one protein 
factor.
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1.2.3 The Role of DNA Methylation in Gene Expression
Cell specific methylation patterns represent an additional 
level of information to the genetic message encoded in DNA. In 
eukaryotes, the function of this additional information remains 
unclear, although various hypotheses for the role of DNA methylation 
have been proposed. These include:
a) Methylation as a marker for the repair of mismatches in
DNA (Meselson, 1975);
b) Methylation as a mechanism for developmental regulation 
(Holliday and Pugh, 1975);
c) Methylation as a regulator of chromosomal replication 
(Taylor, 1977).
In recent years, however, the most widely studied hypothesis
has been the proposed role of methylation in the regulation of gene
expression (Scarano, 1971; Riggs, 1975; Holliday and Pugh, 1975; 
Sager et al, 1975).
Methylation of cytosine residues introduces a methyl group 
into the major groove of the DNA helix (Razin and Riggs, 1980).
This structural alteration may affect the protein-DNA interactions 
necessary for gene transcription. Keshet et al (1986) demonstrated 
that the presence of methyl groups in DNA can affect the chromatin 
structure adopted by genes following their introduction into cells 
by DNA mediated gene transfer. Thus methylation of DNA can result 
in a stable alteration in the local configuration of a gene.
- 9 -
Naveh-Many and Cedar (1981) have demonstrated that all 
active genes- (as measured by DNase 1 sensitivity) from calf thymus, 
chicken erythrocyte and mouse L-cell DNA are undermethylated in 
comparison to the rest of the genome, suggesting that hypomethylation 
is a general phenomenon in actively transcribed genes. In addition, 
Razin and Riggs (1980) noted that certain tissue-specific genes are 
undermethylated only in the tissue in which the gene is expressed.
Tissue specific genes are nearly fully methylated in both 
male and female germ lines, and remain in this state during early 
development and in all non-expressing adult somatic tissues. Only in 
the specific tissue of expression is the gene found to be demethylated. 
In contrast, housekeeping genes which are constitutively expressed in 
all tissues generally contain unmethylated "islands" of CpG both in 
the germ line and in all somatic tissues (Bird, 1985). Many vertebrate 
genes (with the exception of some tissue specific genes) have been 
shown to contain HTF-like sequences in regions of transcriptional 
control.
The original function of methylation in invertebrates 
may have been to inactivate non-coding regions of the genome as no 
transcriptionally active sequences have been found in the methylated 
fraction of invertebrate DNA (Bird et al, 1980). The phenomenon 
of HTF islands in vertebrates may have arisen as the extent of DNA 
methylation and subsequent deamination of 5-mC to thymine spread 
throughout the vertebrate genome. It is possible that selective 
pressure to maintain the promotor region of housekeeping genes 
free from the repressive effects of methylation resulted in the
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constitutive binding of specific factors to DNA, thus sterically 
excluding these regions from the action of DNA methylase. For 
housekeeping genes in particular, it is essential that initiation 
of transcription is not impeded. Holler et al (1988) proposed that 
the constitutive binding of the transcription factor Spl to its 
target sites prevents methylation of these regions. Binding sites 
for this transcription factor are commonly found in HTF islands, 
specifically in the promotor region of genes.
It may be necessary for HTF islands to remain free 
of methylation to allow expression of their associated genes; 
transcription of genes with HTF islands is inhibited when the
island is methylated. For example, on the inactive X-chromosome,
methylated HTF sequences have been found in the region of both 
the hypoxanthine phosphoribosyl transferase (HPRT) and glucose-6- 
phosphate dehydrogenase (G6PD) genes (Toniolo et al, 1984; Yen 
at al, 1984; Wolf et al, 1984).
The presence of unmethylated CpG dinucleotides, the
common feature of HTF sequences, is thought to determine whether 
DNA sequences remain accessible to factors involved in the regulation 
of transcription. DNA-protein interactions may interfere with the 
process of methylation and lead to hypomethylation of certain gene 
sequences. Inactivation of a gene may lead to the displacement 
of bound factors (which normally prohibit methylation) from the 
associated island, thereby allowing access to DNA methylase. 
Methylation may therefore serve as a means of ensuring the continued 
inactivation of certain genes from one cell generation to the next.
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The question remains as to whether demethylation of tissue 
specific genes occurs prior to transcriptional activation. Yisraeli 
et al (1986) demonstrated that methylation inhibits expression of 
the #-actin gene when it is introduced into fibroblasts, but when 
introduced into myoblasts the gene is expressed despite the presence 
of 5-methyl cytosine. Activation of tissue specific genes presumably 
involves recognition of these genes in the methylated state by 
specific transcription factors, and the simultaneous demethylation 
and transcription of these genes. Alternatively, the observation 
that many tissue-specific genes are unmethylated in their "target" 
tissue but methylated in non-expressing cells (Doerfler, 1983) may 
be due to the loss of methyl cytosine at a limited number of 5-mCpG 
dinucleotides following transcriptional activation. Thus under- 
methylation of these genes may be an effect, rather than a cause, 
of transcriptional activation.
The transcription of several genes can be inhibited by 
methylation (Felsenfeld, 1982). Busslinger et al (1983) demonstrated 
that in vitro methylation of the 51 end of a y-globin gene rendered 
the gene inactive, following transformation into mouse cells, while 
transformation of a gene unmethylated at the 5* but methylated in 
the transcribed region resulted in expression of the y-globin gene. 
Similarly, both the hamster adenine phosphoribosyl transferase 
(aprt) gene and the mouse dihydrofolate reductase (dhfr) gene are 
consistently found to be hypomethylated at the 51 end, although 
heavily methylated elsewhere in the gene. Both genes encode essential 
metabolic enzymes, and are therefore expected to be expressed in all
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cells (Stein et al, 1983). In vitro methylation of the hamster aprt 
gene at all CCGG sites by Hpa II methylase inhibits the expression
of this gene in mouse L cells (Stein et al, 1982). These results
suggest that modification of the 5* end of genes by methylation may 
be a factor in the regulation of gene expression.
In contrast, Keshet et al (1985) showed that methylation
of the coding sequences of the Herpes thymidine kinase gene can 
inhibit transcription of the gene in mouse fibroblasts, despite the 
fact that the promotor itself was not modified. This implies that 
methylation at regions outwith the promotor may also impede RNA 
synthesis, presumably by disrupting the binding or activity of 
essential trans-acting factors.
5 azacytidine (5-azaC), an analogue of cytosine,is a 
potent inhibitor of DNA methylase (Jones, 1984). Cells treated 
with 5-azaC have a greatly reduced level of 5-m Cytosine in their 
DNA, and treatment of certain cells with 5-aza C often results 
in the reactivation of hitherto transcriptionally inactive genes 
(Cpinpere et al, 1981; Harris, 1982). Genes on the inactive 
X-chromosome have also been successfully reactivated by treatment 
with 5-azaC (Mohandas et al, 1981).
There is also evidence that genes which have been activated 
in cell lines can be subsequently inactivated by restoration of DNA 
methylation (Hickey et al, 1986; Clough et al, 1986; Flatau et al, 
1984).
It is likely, however, that 5-azaC interferes with a
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variety of general metabolic processes in the cell, and may exert 
effects on gene expression not only by interfering with the action 
of DNA methylase, but also by blocking the interaction of other 
controlling factors with DNA. It is possible that the level of 
methylation is adjusted as a consequence of this latter event.
While there is evidence to suggest that some 5-methyl 
cytosines are involved in the regulation of gene expression, it is 
clear from other studies that a change in the methylation status of 
a gene is not the sole factor involved. In some instances methyl 
groups may generate a local chromatin configuration rendering genes 
inaccessible to transcription factors, but the absence of methylation 
is not sufficient for transcription to occur.
It remains to be demonstrated whether DNA methylation is 
itself a causative factor in the regulation of gene expression or 
if it is merely the result of variations in gene activity. If 
methylation is shown to be actively involved in the regulation 
of transcription, this role is limited to certain organisms and 
possibly even to certain genes. It appears unlikely that 5-methyl 
cytosine was evolutionarily selected and retained in the genome in 
this capacity. The level of cytosine methylation is considerably 
lower in invertebrates than in vertebrates and no definitive example 
of a methylated gene in invertebrates has been found. Drosophila 
melanogastor DNA is not detectably methylated, yet cellular 
determination and differentiation are known to occur. Clearly 
factors other than methylation are involved in the regulation of 
these processes in invertebrates.
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It seems likely that a series of factors will govern 
the control of gene expression. The level of this control may 
vary according to the degree of sophistication of gene regulation 
required by particular organisms. Methylation may be one of a 
number of factors involved in the regulation of certain vertebrate 
genes, perhaps acting to maintain the activation status of particular 
DNA sequences in differentiated cells. While regulation of gene 
expression by selective transcription is one potential point of 
control, it is possible that further regulation of gene expression 
occurs at a later stage, notably in the processing of precursor 
RNA to mature messenger RNA.
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1.2.A DNA Methylation and Differentiation.
The differentiation of cells deriving from a single zygote 
into the highly specialised arrangement of cells and tissues of 
higher eukaryotes is thought to involve a process of determination 
or commitment, when the cell is set on a particular developmental 
pathway. The controls which govern the differentiation of cells are 
likely to involve changes at the level of the genome. There is some 
evidence to suggest that changes in the methylation pattern of DNA 
occur during the process of cellular differentiation, demonstrated 
by tissue specific differences in the 5-methyl Cytosine content of 
DNA (Gama-Sosa et al, 1983; Sano et al, 1982) and the demethylation 
observed at specific sites around active genes (Bird, 1978).
Razin et al (1984) investigated the relationship between 
variations in the levels of DNA methylation and mouse cell 
differentiation. These workers found that mouse teratocarcinoma 
cells induced to differentiate in vitro undergo substantial 
demethylation, losing 30% of methyl moieties following treatment 
with a variety of inducers. More recently (Razin et al, 1988) it 
was shown that in vitro induction of differentiation in Murine 
erythroleukaemia cells (MEL cells) results in a transient genome- 
wide demethylation, followed by remethylation of the DNA. As much 
as 601 of the 5-mC content of the DNA was replaced by Cytosine 
10-18 hours after the induction of differentiation, with remethylation 
completed by 24 hours after induction. It was proposed that changes 
in the methylation pattern may be involved in the commitment of cells 
to differentiate and that erasure of the pre-existing methylation
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pattern would enable the establishment of a new methylation pattern, 
characteristic of the next stage of differentiation. The transient 
replacement of 5-mC by cytosine in the DNA of both MEL cells and 
F9 teratocarcinoma cells (Razin et al, 1984; Bestor et al, 1984) 
strongly implies that the methylation pattern of DNA in induced 
cells is an important factor in the differentiation process.
Chemical inhibition of methylation by 3-deaza-adenosyl 
homocysteine (DZA Hey) was found to inhibit differentiation (Sherman 
et al, 1985; Razin et al 1988) and also completely inhibited the 
hypomethylation of MEL cells.
Events during early mouse development also indicate that 
variations in the pattern of methylation occur during the early 
stages of development. Razin et al (1984) observed a decrease in 
the level of methylation in the yolk sac and placenta of embryonic 
mice, while the DNA of the embryo itself was found to become de 
novo methylated. Such changes in the methylation pattern of DNA 
may be linked to the differentiation mechanism of cells.
Hypomethylation may be a necessary step in the commitment 
of these cells to differentiate, but it is unlikely that hypomethylation 
of DNA is itself sufficient for terminal differentiation to occur.
A series of events, such as the binding of various tissue specific 
trans-acting factors to DNA are likely to control the expression 
of genes in cells undergoing differentiation.
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1.3 Eukaryotic DNA Methylases
1.3.1 Properties of Eukaryotic Methylases
The enzymatic transfer of methyl groups from S-adenosyl-L 
methionine to residues in eukaryotic DNA was first demonstrated by 
Burdon et al (1967) using a crude preparation from Mouse Krebs II 
ascites cells. Since then mammalian DNA methyltransferases have 
been purified from a number of tissues including rat spleen 
(Kalonsek and Morris, 1969), rat liver (Morris and Pih, 1971;
Simon et al, 1978), Hela cells (Roy and Weissbach, 1975), mouse 
ascites cells (Turnbull and Adams, 1976), Bovine Thymus (Sano et 
al, 1985), mouse erythroleukaemic cells (Bestor and Ingram, 1983) 
and human placenta (Pfeifer et al, 1983). The molecular wt of the 
native enzyme is reported in the range 120,000 - 280,000 and may vary 
in different vertebrate tissues. The enzyme isolated from mouse 
ascites cells has a molecular wt in the region of 180,000. With the 
exception of the bovine thymus enzyme, mammalian methylase activity 
is found in the cell nucleus. Adams and Davis (1985) have reported 
the presence of two methylase fractions in a cell homogenate.
One fraction consists of "soluble" enzyme which is only loosely 
associated with the nucleus and can be extracted with dilute salt 
solutions. This fraction accounts for 70-801 of the cell’s methylase 
activity, and the isolated enzyme is capable of both maintenance and 
de novo methylation. The remaining enzyme activity stays firmly 
bound in the nucleus, even under 2M NaCl extraction conditions. The 
bound form of the enzyme may be associated with a nuclear matrix­
like structure near the replication fork of DNA (Burdon et al, 1985). 
Bound enzyme has been shown to act predominantly on cytosine residues
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in the nascent strand of a DNA duplex following replication, and 
thus appears to function mainly as a maintenance enzyme.
When solubilised, the properties of the bound form of 
DNA methylase are similar to those of the soluble enzyme fraction, 
with regard to substrate requirement, ionic requirement and pH 
optima (Burdon et al, 1985) and it is likely that the two fractions 
represent the same catalytic molecule. In vivo, the soluble enzyme 
is thought to become firmly, though transiently, bound with DNA 
in the nuclear matrix structure, being released again only after 
methylation has taken place. The soluble fraction may simply 
represent a circulating pool of enzyme available for attachment at 
sites within the nucleus, or it may have a more individual role in 
the cell, possibly in the methylation of repaired stretches of DNA 
(Kastan et al, 1982).
1.3.2 Substrate Specificity and Requirements
DNA methylases isolated from eukaryotes have no co-factor 
requirement, and are in fact inhibited by most divalent cations 
with the exception of Mg^+ and Ca^+ (Adams and Burdon, 1983).
Enzyme activity is enhanced in the presence of chelating agents.
The preferred substrate for known eukaryotic DNA methylases 
is the unmethylated strand in a hemi-methylated duplex, where 
the methylation rate is 10-30 X greater than that of de novo 
methylation. In low salt, enzyme molecules are known to aggregate. 
This condition also allows the DNA duplex to "breathe", that is, 
single stranded regions become available. It is thought that only 
under these conditions can DNA methylase bind and interact with
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DNA (Adams, 1979). This is supported by EH data of Pfeifer et al 
(1985) which indicates that mouse DNA methylase preferentially 
binds to single stranded regions of DNA. In vivo, such regions 
will occur at the sites of DNA replication and excision repair.
Proteins associated with DNA in vivo may interfere 
with the ability of the enzyme to modify CpG sites. In isolated 
nuclei, methyl groups are preferentially added to DNA which is 
susceptible to digestion with micrococcal nuclease (Razin and 
Cedar, 1977) implying that DNA binding proteins may inhibit the 
action of DNA methylase. This was confirmed by'Kautiainen and Jones
(1985). Studying the effects of DNA binding proteins on methylation 
they demonstrated that hemi-methylated CpG sites which are readily 
methylated in purified DNA may remain unmethylated when DNA is 
associated with chromatin proteins. Histones became associated with 
DNA shortly after synthesis, forming nucleosomal structures: Core
histones are deposited within ten minutes and linker histones ten 
to twenty minutes after replication, an association known to inhibit 
methylation (Davis et al 1986). This effect is probably due to a 
close association of protein with the methyl acceptor site in DNA.
1.3.3 Methylation and DNA Synthesis
Although initiation of methylation occurs shortly after DNA 
synthesis, a period of several hours may elapse before methylation of 
the nascent DNA is complete (Burdon et al, 1969; Evans et al, 1973; 
Adams, 1971; Adams, 1974; Geraci et al, 1974; Theiss et al, 1978; 
Kiryanov et al, 1980).
Woodcock et al (1983) demonstrated that in several mammalian
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cell lines this "delayed" methylation is completed prior to the next
S-phase and initiation of a new round of DNA replication - presumably
essential to'avoid loss of methylation patterns.
A short lag of about one minute between synthesis and 
methylation (reported by Kappler, 1970 and Gruenbaum et al, 1983) 
may be due to the ligation of Okazaki fragments in the nascent DNA 
strand prior to methylation (Adams, 1974; Hotta and Hecht, 1971; 
Drahorsky and Wacker, 1975). One cause of the longer delay in 
the completion of methylation in vivo is almost certainly due 
to the association of proteins, such as histones, with DNA. Such 
interactions interfere with the action of DNA methylase, resulting 
in the persistence of hemi-methylated sites in DNA for several
hours after replication. Woodcock et al (1984) suggested that
two different enzyme activities are responsible for immediate and 
delayed methylation, citing different sensitivities of "immediate" 
and "delayed" methylase to inhibitors.
Since no distinct differences have been found between DNA 
sequences methylated immediately or after a delay (Woodcock et al,
1984) it seems likely that the second enzyme would act as an accessory 
to the first, restoring symmetry to remaining hemi-methylated sites 
following passage of the replication fork and the binding of 
chromatin proteins; Some time may elapse before methylase has 
access to all hemi-methylated sites in nucleosomal DNA.
Davis et al (1985) showed that nuclear matrix-associated 
DNA methylase (see Section 1.3.1) was responsible for delayed
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methylation in mammalian nuclei. This enzyme fraction may also 
be responsible for delayed methylation in vivo.
1.3.4 Establishment and Maintenance of Methylation Patterns
The methylation patterns in mammalian cell DNA are 
heritable in a tissue and species specific manner (Bird, 1984; 
Doerfler, 1983; Jaenisch et al, 1984; Razin et al, 1984).
The methylation patterns within cellular DNA are believed to 
be established during embryogenesis, and are subsequently 
maintained in a stable state throughout somatic cell division.
As described in Section 1.3.2 the preferred substrate for 
known eukaryotic methylases is the unmethylated strand in a hemi- 
methylated duplex, where the rate of methylation is 10-30 X that of 
de novo methylation (Gruenbaum et al, 1982; Bolden et al, 1984).
Be novo and Maintenance Methylation
De novo methylation - methylation of symmetrical 
unmethylated CpG dinucleotides has been shown to occur in early 
mammalian embryos (Jahner et al, 1982; Brinster et al, 1983). As 
described in Section 1.2.1, it is highly unlikely that methylation 
of CpG sites is random - it appears that the enzyme preferentially 
methylates certain CpG sites during de novo methylation (Pfeifer,
1985). The function of this modification in undifferentiated cells 
may be to selectively control gene expression (Riggs and Jones, 
1983). Alternatively, de novo methylation may be a secondary 
consequence of gene inactivation (by some other means) and may 
function to imprint the inactivity of these sequences throughout
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successive cell generations (Bird, 1986). Inhibition of de novo 
methylase activity is observed upon prolonged incubation of the 
enzyme with high concentrations (200-300 ug/ml) of unmethylated 
double stranded DNA (Palitti et al, 1987). The inactivation process 
appears to be the result of a progressive interaction of the enzyme 
with DNA, independent of the presence of S-adenosyl-L-methionine, 
suggesting that de novo methylating activity could be regulated 
by DNA itself.
Maintenance methylation, the continuance of pre-existing 
methylation patterns in DNA following DNA synthesis, is probably 
essential for maintaining phenotypic stability of differentiated 
cells (Doerfler, 1983; Razin and Riggs, 1980). Holliday and Pugh 
(1975) and Riggs (1975) suggested that methyl groups on cytosine 
residues are inherited in a semi-conservative fashion following 
DNA synthesis. The combination of the symmetrical placement of 
methylated residues on the DNA duplex coupled with an enzyme acting 
preferentially at hemi-methylated sites (confirmed by Adams et al, 
1979) would facilitate the stable inheritance of the methylation 
pattern following DNA replication. The totality of this theory has 
been challenged more recently by Bolden et al (1987) whose results 
suggest that the placement of methyl moieties on cytosines in the 
daughter strand of the duplex following DNA synthesis is at least 
to some extent determined by the primary sequence of this target 
strand, and is not solely determined by the methylation pattern 
in the complementary parent strand.
Most somatic cell methylation is believed to be carried
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out by a maintenance enzyme (Gruenbaum et al, 1982). However, there 
is no direct evidence for the existence of distinct de novo and 
maintenance methylase activities, since all DNA methylases isolated 
to date exhibit both activities, and it is believed that one enzyme 
species performs both reactions (Pfeifer et al, 1983; Grunwald et 
al, 1984). Bestor and Ingram (1983) demonstrated that the ratio of 
maintenance : de novo enzyme remains unchanged during purification, 
while both enzyme activities were shown to be inhibitied by the 
same monoclonal antibody (Drahovsky, 1984).
The dual functions presumably result from modification 
of enzyme activity, either indirectly by the influence of cellular 
factors, or by a change in the nature of the enzyme itself, 
possibly a structural modification, influencing its activity on 
different DNA substrates. Such modulations may be essential to 
enable site specific de novo methylation to occur during the 
establishment of methylation patterns in differentiating cells, 
and prevent inappropriate de novo methylating events which would 
interfere with the existing tissue specific methylation pattern 
in the cell, whilst allowing the stable inheritance of methylation 
patterns from one somatic cell generation to the next.
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1.4 Structure and Mode of Action of DNA Methylase
1.4.1 Preliminary Studies on DNA Methylase
Total purification of DNA methylase has proved difficult 
due to the low levels of enzyme found in cells, and the instability 
of the enzyme in vitro: DNA methylase immunoprecipitated from two
human cell lines indicated that the enzyme represents approximately 
0.002Z of the total protein (Pfeifer et al, 1986), while Adams et al
(1986) found that enzyme incubated in the absence of substrate for 
six hours at 37°C subsequently loses 62Z of its activity on single 
stranded DNA and 39Z of its activity on a native DNA substrate.
Pfeifer et al (1986) demonstrated that affinity purified DNA methylase 
from mouse P815 mastocytoma cells was liable to proteolytic degradation 
when incubated at 20°C for 16 hours: following SDS polyacrylamide
gel electrophoresis the 190 kD native enzyme was found to be converted 
to smaller polypeptides of 175 kD, 150 kD, 130 kD and 115 kD. It 
is not clear whether this decomposition is due to the presence of 
endogenous proteinases in the enzyme preparation or if the enzyme 
itself is capable of autocatalysis. The same authors have shown that 
the composition of the purified protein is to some extent dependent 
on the purification procedure employed. The lower molecular mass 
polypeptides may still be enzymatically active as no substantial 
loss of enzyme activity is reported. Another possibility is that 
the "cleavage" event merely involves the introduction of nicks at 
various sites within the enzyme, which do not cause dissociation 
of the enzyme in vitro, but which are sufficient to cause it to 
dissociate upon SDS gel electrophoresis.
Some form of enzyme cleavage, either by autocatalysis
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or by the action of a specific proteinase may occur in vivo as 
a means of modulating the activity of DNA methylase on different 
substrates. . For example, while maintenance and de novo methylation 
are believed to be carried out by the same enzyme, some structural 
modification may be necessary to facilitate methylation at CpG 
dinucleotides without recognition of 5-mC on the opposite strand.
1.4.2 Factors Influencing the Binding of DNA Methylase
to DNA and the Rate of the Methylation Reaction
While the initial binding of DNA methylase to a DNA 
polymer does not require the presence of methylatable cytosines 
(Drahovsky et al, 1972; Bolden et al, 1984) it is likely that 
flanking sequences will influence the binding and catalytic action 
of the enzyme. The number and spacing of CpG sites are likely to 
be important factors, as is the length of the DNA polymer itself. 
Pfeifer et al (1985) found that a minimum length of 90 base pairs 
of DNA was required for the binding reaction of affinity purified 
human DNA methylase, although binding was apparently independent 
of the nucleotide composition of the DNA and the presence of 
S-adenosyl-L-methionine.
The rate of methylation on native DNA is likely to be 
influenced by the number of CpG sites available for methylation.
In higher eukaryotes, DNA is deficient for CpG and a large 
proportion of the CpG sites present are already methylated. Km 
values of 30 to 70 mg/ml have been found for the native DNA of 
higher eukaryotes in comparison with the much lower Km values 
(0.5 to 2.5 ug/ml) found for native unmethylated bacterial DNA
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and insect DNA.
In-higher eukaryotes, even under conditions of a vast 
excess of enzyme to DNA (one enzyme molecule for twelve base 
pairs of DNA) over forty hours elapses before completion of the 
methylation reaction, using M. luteus DNA as a substrate. This 
lag may be due to an initial failure to methylate at certain 
sites by the enzyme, perhaps as a result of the proximity of CpG 
sites and the inability of the enzyme to recognize or gain access 
to all available sites.
1.4.3 Models for DNA Methylase Structure
and the Enzymatic Methylation of DNA
Due to the difficulties of isolating sufficient quantities 
of purified DNA methylase, details of the structure and mode of 
catalysis of the enzyme are still speculative. It is presumed 
that DNA methylase will have domains for the recognition of paired 
unmethylated CpG dinucleotides as well as domains for the binding 
of S-adenosyl-L-methionine and DNA.
An early model for the enzymatic methylation of DNA by 
Drahovsky and Morris (1971) envisaged the enzyme binding to a DNA 
molecule at or near one end and "walking" along the molecule, 
methylating sites as it encountered them. The results of Turnbull 
and Adams (1976) disputed this as a plausable mechanism, finding 
that mouse ascites DNA methylase binds loosely and reversibly to 
DNA molecules, methylating only when it binds to CpG sites. More 
recently Burdon and Adams (1983) surmised that DNA methylase can
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travel along a DNA polymer, dissociating when it reaches the end 
of the molecule and also perhaps at certain randomly positioned 
sequences such as fully methylated CpG dinucleotides.
Speiss et al (1988) analysed the structure of DNA
methylase purified from mouse P815 mastocytoma cells by electron
microscopy. The resulting schematic model depicted a hemi- 
elliptical globular structure bearing a small projection. It 
has been proposed that the globular mass carries the methylation 
centre of the enzyme with the appendix perhaps representing the 
CpG recognition site, although further work is required before 
definitive functional roles can be assigned to the morphological 
domains identified so far.
1.4.4 Cloning of Mammalian DNA Methylase
Bestor et al (1988) have recently cloned and sequenced a
cDNA coding for DNA methylase from Friend erythroleukaemia cells.
The protein was found to consist of a 1000 amino 
acid N-terminal region and a 570 amino acid C-terminal region.
The latter was shown to bear significant homology to bacterial 
type II restriction methyltransferases, suggesting a common 
ancestry of mammalian and bacterial methyltransferases; this 
region is proposed to contain the catalytic centre of the enzyme, 
represented by the sequence motif Pro Cys Xg Gly.
No enzymatic function has yet been assigned to the 
N-terminal region. This domain contains a cysteine-rich region 
characteristic of the consensus sequence for metal binding 
"fingers" found in other nucleic acid binding proteins (Evans
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et al, 1988), although it remains to be established whether nhe 
N-terminal region does bind metal ions. Proof of a metal rinding 
capacity may indicate a role for the N-terminal domain in the 
regulation of enzymatic methylation by the C-terminal domain.
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1*5 Methods and Approaches to Studying DNA Methylase
DNA methylase activity is predominantly present in 
rapidly dividing cells, with negligible activity detected in 
stationary cells. The enzyme, however, represents only a very 
small proportion (approximately 0.002Z) of the total cell protein 
(Pfeifer et al, 1986) and is in addition extremely heat labile 
and prone to degradation during purification. Thus considerable 
difficulties have been encountered in attempts to purify DNA 
methylase to homogeneity, and in the study of the enzyme in vivo. 
Simple extraction and assay of DNA methylase from cells often 
provides little information as synthetic DNA substrates may prove 
ineffective in reflecting the in vivo activity of the enzyme.
In order to study DNA methylase itself and the effect of 
methylation on DNA, both purified enzyme and a means of precise 
detection of enzyme in vitro and in vivo are required. The 
use of monoclonal and polyclonal antibodies directed against 
epitodes specific to DNA methylase used in conjunction with 
immunodetection techniques should provide a means of identifying 
DNA methylase activity in cells, from enzyme synthesis to 
degradation.
To maximise enzyme yields, the purification strategy 
requires the use of selected purification procedures, chosen 
for rapid and efficient recovery of enzyme with minimal loss of 
enzyme activity. The recovery of purified, active DNA methylase 
is essential for in vitro analysis of size, reactivity and 
stability of the enzyme.
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The application of these techniques should provide 
us with a greater understanding of both DNA methylase and the 
methylation reaction, and of the effect of DNA methylation on 
cellular development.
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CHAPTER 2 : MATERIALS AND METHODS
2.1 Materials
2.1.1 Chemicals
General chemicals used were of analytical grade and were 
supplied by The British Drug House, Dorset, UK. Chemicals obtained 
from other sources are listed below:
Sigma Chemical Co Ltd, Dorset, UK
Aminopterin, Bovine serum albumin, Coomassie Blue (G), Ethidium 
bromide, Hypoxanthine,a2-macroglobulin, o-Phenylene diamine, 
Phosphorylase B, Phenyl methyl sulphonyl fluoride, Thymidine, 
Trypsin, Trypsin inhibitor, Tween 20 (Polyoxyethylene sorbitan 
monolaureate), Tween 80 (Polyoxyethylene sorbitan mono oleate).
Koch-Light Laboratories, Bucks, England, UK 
m-Cresol, Dimethyl sulphoxide, Triton X-100.
FSA Supplies, Loughborough, England UK
Acrylamide, N.N1methylene bisacrylamide, Sodium dodecyl sulphate. 
Boehringer-Mannheim, East Sussex, UK
Dithiothreitol, Polyethylene glycol 1500, Tris (hydroxymethyl) 
methylamine.
Amersham International PLC, England, UK
Biotin-Streptavidin detection system, Hybond-C hybridisation 
transfer membrane.
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Miscellaneous
Ammonium sulphate was supplied by Fisons PLC, Loughborough, UK; 
Egoscint scintillation fluid was supplied by National Diagnostics, 
New Jersey, USA; Salicylic acid was supplied by Aldrich Chemical 
Company Ltd, Dorset, UK; Heat Reactivated horse serum was from 
Gibco, Paisley, Scotland; Pansorbin was supplied by Behring 
Diagnostics, La Jolla, California, USA; Freund’s adjuvant was 
from Difco Laboratories, Detroit, USA; Fuji Rx x-ray film was 
from Fuji Photo Film Co Ltd, Tokyo, Japan; Millex-GS filter 
units were supplied by Millipdgje SA, France; Whatman filter 
paper was from H. Reeve-Angel & Co Ltd, London,' UK.
2.1.2 Nucleic Acids 
Micrococcus luteus DNA 
d)X174 RF DNA
Salmon testes DNA 
E. coli transfer RNA
were supplied by Sigma Chemical Co, Poole, Dorset, UK.
2.1.3 Restriction Enzymes
Restriction enzymes and REact buffers were obtained 
from Bethesda Research Laboratories, Cambridge, UK.
2.1.4 Radiochemicals
S-adenosyl-L-[Methyl H^] methionine (^ H Ado Met) 
was obtained from the Radiochemical Centre, Amersham, England.
-ipc
x^JI-NaI was supplied by the Western Infirmary, Glasgow 
University, Scotland.
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2.1.5 Chromatography Media 
CN Br Sepharose 
Heparin Sepharose 
Sephacryl S300 
Sephadex G50
QAE Sephadex A50
were supplied by Pharmacia Ltd, Milton Keynes, UK. 
Cellulose Phosphate Pll
was supplied by Whatman Biosystems Ltd, Maidstone,
Kent, UK.
2.1.6 Cell Culture Materials
RPM1 1640, Glasgow MEM, MEM without L-methionine, Foetal 
calf serum, Newborn calf serum, L-Glutamine, Non-essential amino 
acids, Sodium bicarbonate were supplied by Gibco Ltd, Paisley, 
Scotland.
2.1.7 Cell Lines
The rat myeloma cell line Y3.Ag.l.2.3 was obtained from 
the MRC Laboratory of Molecular Biology, Cambridge, UK.it^ alffe et .al
2.1.8 Animals
DA rats were propagated in the animal house of Glasgow 
University, Biochemistry Department.
2.1.9 Disposable Plasticware
96 well microtitre ELISA plates were supplied by Dynatech
. 1979)
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Laboratories Ltd, Sussex, UK.
Tissue culture plates (96 well and 24 well) and Biofreeze vials were 
supplied by Costar, Northumbria Biologicals Ltd, Northumbria, UK. 
Tissue culture flasks (25 cm2, 75 cm2 and 125 cm2) were supplied 
by Coming Glass Works, New York, USA.
Petridishes and sterile syringes were supplied by Becton Dickinson 
and Co Dublin, Eire.
Centrifuge tubes were supplied by Elkay products Inc, MA, USA.
2.1.10 Solutions
2.1.10.1 SDS Mix
12 (w/v) SDS
2 mM EDTA
52 (v/v) Butanol
2.1.10.2 Stopper
3 g p-amino salicylic acid 
0.125 M Nacl
25 mg salmon testes DNA
50 ml SDS mix (see section 2.1.10.1)
Adjust volume to 100 ml with dH20
2.1.10.3 Phenol Mix
1 'B8f (v/v) phenol 
122 (v/v) m-Cresol 
0.12 (w/v) 8-hydroxyquinoline.
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2.1.10.4 Bradford’s Reagent
100 mg Coomassie Brilliant Blue G was dissolved in 
a 50 ml solution of 952 ethanol in dH20. 100 ml of 852 (w/v) 
phosphoric acid was added, and the solution made to one litre 
with dH20. The solution was filtered on Whatman No 1 filter 
paper and stored in the dark.
2.1.10.5 Ado r3H1 Met Stock Solution 
25pCi TRA (0.5pCi/p.l)
300\iCi TRK (1 pCi/jil)
2650*11 dH20
2.1.10.6 Preparation of HT and HAT Medium
100 x HT Stock solution containing 10 m®hypoxanthine 
and 1.6 m5Bthymidine, was prepared by dissolving 1.36 mg 
hypoxanthine plus 39 mg thymidine in dH20 to a final volume 
of 100 ml. The solution was heated to 60°C to dissolve the 
hypoxanthine and filter sterilised.
100 X Aminopterin stock (4 x 10"^M) was prepared separately 
to a final concentration of 1.8 mg aminopterin/100 ml dH20.
The solution was filter sterilised and stored in the dark at 
-20°C.
50 X HAT stock was prepared by mixing equal volumes of stock HT 
and Aminopterin. The solution was aliquoted in small volumes 
and stored at -20°C in the dark.
HT and HAT medium were diluted in complete medium before 
dispensing to cells on microtitre plates.
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2.1.10.7 Cell Culture Solutions
2.1.10.7.1 Complete Medium 
RPM1 1640
2 mM L-Glutamine
12 (v/v) non-essential amino acids 
Supplemented with 102 (v/v) or 202 (v/v) foetal 
calf serum.
2.1.10.7.2 Serum-Free Medium 
RPM1 1640
2 mM jjLj-Glutamine
12 (v/v) non-essential amino acids 
The composition of RPM1 1640 is shown in Table 1, 
The composition of non-essential amino acids is 
shown in Table 2.
2.1.10.7.3 EC 10 Medium 
450 ml dH20
50 ml Glasgow (MEM) 10 X cone 
102 (v/v) newborn calf serum 
2 mM L-Glutamine 
252 (v/v) sodium bicarbonate
2.1.10.7.4 Minus Methionine Medium
MEM minus L-methionine medium 
102 (v/v) newborn calf serum
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2.1.11 Buffers
2.1.11.1 Buffer M
50 mM tris HC1 pH 7.8 
ImM EDTA 
1 mM DTT
0.01% (w/v) NaN3 
10% (v/v) glycerol
6 mg/ml PMSF in ethanol was added to buffer M 
at 1% (v/v) immediately before use.
2.1.11.2 Phosphate Buffered Saline 
PBS A : 10 g/1 NaCl
0.25 g/1 KC1 
1.44 g/1 Na2HP04 
0.25 g/1 KH2P04 
PBS B : 1 g/1 CaCl2 
PBS C : 1 g/1 MgCl2dH20
Phosphate buffered saline was prepared as three 
separate solutions (A, B and C) and mixed in the 
ratio 8:1:1 before use.
2.1.11.3 Immunoblotting Buffer 
20 mM tris HC1 pH 7.2 
0.15 M NaCl
0.5% (v/v) Tween 20 
0.5 mg/ml NaN3
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2.1.11.4 ELISA Buffers
PBS
0.5 mg/ml BSA 
PBS
10 rag/ml BSA 
PBS
0.12 (v/v) Tween 20 
PBS
12 (w/v) BSA
Antibody Diluent
Blocking Buffer
Wash Buffer
Conjugate Diluent
Citrate Phosphate Buffer (McILVAINE’S BUFFER)
Solution A : 0.1 M citric acid 
Solution B : 0.2 M Na2HP04 12 H20
17.9 ml of solution A was added to 32.1 ml of solution B 
and the pH adjusted to 6.0 with HC1. The solution was 
made to a final volume of 100 ml with dH20.
OPD Solution (Developer)
4 mg OPD 
0.012 H202
9 ml citrate phosphate buffer 
4N H2S04 to stop the reaction
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2.1.11.5 Immunoprecipitation Buffers 
TKM Buffer 
100 mM tris 
100 mM KC1 
5 mM MgCl2 
5N HC1 to pH 8.2 
TKM/Triton X-100 Buffer 
100 mM tris 
5N HC1 to pH 8.2 
100 mM KC1 
5 mM MgCl2
1Z (v/v) Triton X-100 
1Z (w/v) sodium deoxycholate 
0.5Z (w/v) SDS
2.1.12 Electrophoresis Solutions and Buffers
2.1.12.1 Polyacrylamide Gel Buffers
Resolving Gel Buffer
1.5 M tris 
0.4Z SDS
5N HC1 to pH 8.8 
Stacking Gel Buffer 
500 mM tris 
0.4Z SDS
5N HC1 to pH 6.8
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Acrylamide Stock Solution
302 (w/v) acrylamide
0.82 (w/v) N.N1- methylene bisacrylamide
Ammonium Persulphate Stock Solution
102 (w/v) ammonium persulphate in dH20
SDS Sample Buffer
0.1875 M tris HC1 pH 6.8
62 (w/v) SDS
302 (v/v) glycerol
152 (v/v) 2-mercaptoethanol
0.0032 (w/v) bromophenol blue
Reservoir Buffer
25 mM tris
0.19 M glycine
0.12 (w/v) SDS
2.1.12.2 Agarose Gel Buffers 
Reservoir Buffer 
50 mM tris pH 8.3 
400 mM boric acid 
5 mM EDTA 
Sample Buffer 
252 (v/v) glycerol 
22 (w/v) SDS
0.0252 (w/v) bromophenol blue
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2.1.12.3 Immunoblot Transfer Buffer
25 mM tris pH 8.3 
0.192 M glycine 
202 (v/v) methanol 
0.022 (w/v) SDS
2.1.13 Stains and Destains 
Coomassie Stain 
0.12 (w/v) Coomassie Blue G 
502 (v/v) methanol 
102 (v/v) acetic acid 
Destain 
102 methanol 
102 acetic acid.
Amido Black Stain 
0.12 (w/v) Amido Black 
452 (v/v) methanol 
102 (v/v) acetic acid 
Destain
452 (v/v) methanol 
102 (v/v) acetic acid
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TABLE 1 : COMPOSITION OF RPM1 1640
mg/litre
Ca (N03) 2 69.49
KC1 400.0
MgS04 7H20 100.0
NaCl 6000
NaHC03 2000
Na2HP04 800.7
Glucose 2000
Sodium phenol red 5.00
L-arginine Hcl 200.0
L-asparagine H20 56.82
L-aspartic acid 20.00
L-cysteine disodium salt 59.15
L-glutamic acid 20.00
L-glutamine 300.0
Glutathione 1.00
Glycine 10.00
L-histidine HC1 H20 15.00
L-hydroxyproline 20.00
L-isoleucine 50.00
L-leucine 50.00
L-lysine HC1 40.00
L-methionine 15.00
L-phenylalanine 15.00
L-proline 20.00
L-serine 30.00
L-threonine 20.00
L-tryptophan 5.00
L-tyrosine 20.00-
L-valine 20.00
Biotin 0.20
D-Ca pantothenate 0.25
Choline chloride 3.00
Folic acid 1.00
I-Inositol 35.00
Nicotinamide 1.00
p-aminobenzoic acid 1.00
Pyridoxal HC1 1.00
Riboflavin 0.20
Thiamin HC1 1.00
Vitamin B12 0.005
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TABLE 2 : COMPOSITION OF NON-ESSENTIAL AMINO ACIDS
L-alanine 
L-asparagine H20 
L-aspartic acid 
Glycine
L-glutamic acid 
L-proline 
L-serine
mg/litre
8.9
15.0
13.3
7.5
14.7
11.5
10.5
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2.2 Methods
2.2.1 Purification of DNA Methylase from 
Mouse Krebs II Ascites Tumour Cells
2.2.1.1 Propagation of Krebs II Ascites Cells in Mice
Krebs II ascites cells were propagated and maintained in 
Porton mice by the method of Martin et al (1961). The cells were 
harvested after seven days of growth as described by Turnbull and 
Adams (1976).
2.2.1.2 Preparation of Nuclei from Krebs II Ascites Cells 
Nuclei were prepared from mouse Krebs II ascites cells by
the method of Turnbull and Adams (1976) and stored at -70°C before 
use. All purification procedures were carried out at 4°C.
2.2.1.3 Extraction of DNA Methylase from Nuclei
Frozen nuclei were thawed quickly at 37°C and removed to 
4°C. The nuclei were stirred with an equal volume of buffer M until 
clumps had dispersed, followed by two volumes of buffer M containing 
0.4 M NaCl. The nuclei were stirred for ten minutes and centrifuged 
at 1000 g, for 15 min. The supernatant was removed and the pellet 
stirred with a further 1 volume of buffer M and 1 volume of buffer M 
containing 0.4 M NaCl. The nuclei were centrifuged as above, and the 
supernatants from the two spins pooled (Fraction II).
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2.2.1.4 Preparation of Phosphocellulose
Phosphocellulose Pll cation exchange matrix was swollen 
according to manufacturer’s instructions, then stirred with buffer 
M containing 1 mg/ml BSA. The matrix was washed in buffer M, then
in buffer M containing 0.6 M NaCl until the E280 value was < 0.01.
The phosphocellulose was re-suspended in an equal volume of buffer 
M containing 0.2 M NaCl to give a 502 (w/v) phosphocellulose 
suspension and stored at 4°C.
2.2.1.5 Phosphocellulose Chromatography
Fraction II was absorbed onto phosphocellulose in buffer 
M containing 0.2 M NaCl. 12 ml of 502 (w/v) phosphocellulose 
suspension was used per 100 ml fraction II. The mixture was stirred 
for 20 min at 4°C and centrifuged at 1000 g for 10 min. The pellet 
was washed twice in buffer M containing 0.2 M NaCl, and the enzyme 
eluted batchwise with buffer M containing 0.5 M NaCl (Fraction III).
2.2.1.6 Ammonium Sulphate Precipitation
Fraction III was made 502 saturated with respect to
ammonium sulphate. The solution was stirred for a further 20 min
and centrifuged at 14000 g for 20 min. The supernatant was 
discarded.
2.2.1.7 Gel Filtration on Sephacryl S300
The pellet was re-dissolved in 10 ml of buffer M and 
applied to a column of Sephacryl S300 equilibrated with the same 
buffer. The enzyme was eluted with buffer M containing 0.2 M NaCl. 
Fractions eluting at 1.15 - 1.6 X void volume were pooled (Fraction
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IV) and made to 702 saturation with ammonium sulphate. The solution
was stirred and centrifuged as described above.
2.2.1.8 Preparation of tRNA Sepharose
, 3g of_|cN-Br Sepharose was swollen and washed by a method 
recommended by the manufacturer. 10 mg of E. coli tRNA was dissolved 
in a buffer containing 0.1 M NaHC03/0.5 M NaCl pH 8.3, and mixed 
with the gel for 12 h at 4°C. Excess ligand was removed by washing 
with the same buffer, and remaining active groups were blocked using 
0.1 M tris HC1 pH8. The gel was then washed with three cycles of 
alternating pH using:
(a) 0.1 M sodium acetate
0.5 M NaCl pH4
(b) 0.1 M tris
0.5 M NaCl pH8
2.2.1.9 Affinity Chromatography on tRNA Sepharose
The pellet obtained in Section 2.2.1.7 was redissolved 
in 1 ml of buffer M and desalted on a 19 ml Sephadex G50 column.
The non-retarded fraction was bound directly onto a 10 ml tRNA 
Sepharose column, and the enzyme eluted with buffer M containing 
0.2 M NaCl (Fraction V).
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2.2.1.10 Assay of DNA Methylase Activity
2.2.1.10.1 Preparation of Denatured M. luteus DNA
M. luteus DNA was dissolved in 50 mM KC1 to a final 
concentration of 0.5 mg/ml, and heated to 100°C for 10 min. The 
solution was cooled on ice and stored at -20°C.
2.2.1.10.2 DNA Methylase Assay
DNA methylase activity was assayed in a final volume 
of 70 ml containing 5 mg M. luteus DNA, 3♦3 pM Is-adenosy1 L-[Me-H^] 
methionine, 50 mg BSA and enzyme in buffer M. When denatured 
M. luteus DNA was used as the substrate, 100 mM NaCl was also 
included. The reaction mixture was incubated at 37°C for 1 h 
and the reaction stopped by addition of 0.5 ml of stopper 
solution (2.1.10.2). Protein was removed by treatment with 
phenol containing!^ 8-hydrqxyquinpline {and m-cresol, and the DNA 
was isolated by precipitation with two volumes of ethanol. RNA 
was removed by incubation with 50pl 0.3 M NaOH, at 37°C for 1 h.
The DNA was precipitated onto 3 mm Whatman filter squares using 
52 (v/v) trichloroacetic acid in which the filters were washed 
four times. The filters were then washed in methylated spirits, 
dried in ether, placed in scintillation vials and incubated with 
0.5 ml of 0.5 N perchloric acid at 60°C for 30 min. 5 ml of 
Ecoscint scintillation fluid was added and the samples counted 
on a Beckman scintillation counter.
One unit of activity is defined as the amount required 
to catalyse the incorporation of one pmol of methyl groups into
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M. luteus DNA in 1 h at 37°C under standard assay conditions.
2.2.1.10.3 Measurement of Protein
The protein content of samples was assayed by the method 
of Bradford (1976) using bovine serum albumin as a standard.
2.2.1.11 Polyacrylamide Gel Electrophoresis 
8.752 (w/v) Resolving Gel 
10 ml stock buffer;
11.7 ml acrylamide stock;
18 ml dH20;
50pl TEMED;
200pl ammonium persulphate stock.
62 Stacking Gel
5.5 ml dH20;
2.5 ml stock buffer;
2 ml acrylamide stock;
75jil TEMED;
150jil ammonium persulphate stock.
Preparation of Samples for PAGE
20 ml of gel sample buffer was added to each of the 
protein samples which were then heated to 100°C for 10 min, before 
applying to a polyacrylamide slab gel. Gels were subjected to 
electrophoresis for 5 h at 40 mA.
2.2.1.12 Preparation of Polyclonal Antiserum Against DNA Methylase 
Preparation of polyclonal antiserum in rabbits against
[■—  : — — :T7
mouse DNA methylase was described by Adams et al (1986).1 "
Rabbits were subcutaneously injected with purified DNA methylase
in Freund’s complete adjuvant and given booster injections after j
! 3 weeks and 6 weeks. After a further 2 weeks the rabbits were
bled and Serum recovered. The antibody titre by ELISA whs 
1/12800 (see Figure 6).
2.2.1.13 Immunoblotting
Following gel electrophoresis, proteins were transferred 
onto a nitrocellulose membrane by the method of Towbin (1979).
The membrane was washed in immunoblotting buffer (Section 2.1.11.3) 
and incubated in the same buffer containing 12 (v/v) heat-inactivated 
horse serum and 0.032 (v/v) polyclonal antiserum (Section 2.2.1.12) 
for 2 h at RT. The membrane was washed as above and incubated with 
lpCi I^^-labelled protein A in blotting buffer for 2 h at RT.
1 p e
Unbound Ix -protein A was removed by washing in blotting buffer.
The membrane was dried overnight and autoradiographed.
2.2.1.14 Immunoprecipitation of Mouse DNA Methylase
2.2.1.14.1 Radiolabelling of Mouse L929 Cells
6 p5 x 10° mouse L929 cells were grown in 75 cm^ flasks 
containing 802 (v/v) MEM minus methionine medium plus 102 (v/v)
EC10 for one hour at 37°C. 500|iCi of ^S-methionine was then
added to the medium and the cells were incubated at 37°C. The
cells were harvested 18 hours and 48 hours after addition of
the radioactive marker, and nuclei were prepared.
2.2.1.14.2 Preparation of Nuclei from Mouse L929 Cells
The cell medium was discarded and the flasks rinsed 
twice in PBS. The cells were scraped into PBS and pelleted by 
centrifugation at 1000 g for 5 min. The pellet was re-suspended
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in 1 ml PBS containing 12 (v/v) Tween 80 and 12 (v/v) PMSF 
solution (6 mg/ml PMSF in ethanol). The cell suspension was 
homogenised at 600 rpm and the homogenate centrifuged at 1000 g 
for 10 min. The nuclei were re-suspended in two volumes of 
buffer M containing 0.4 M NaCl, and vortexed for 10 min at 4°C. 
Following centrifugation at 1000 g for 5 min, the supernatant 
obtained was used for immunoprecipitation of DNA methylase.
2.2.1.14.3 Pansorbin Preparation
100 pi of Pansorbin (standardised 5. aureus cells) was 
centrifuged at 13000 rpm for 5 min and the supernatant discarded.
The pellet was washed in TKM/Triton X-100 buffer, and centrifuged 
as above. The pellet was re-suspended in 1 ml of the same buffer. 
50pl of the washed Pansorbin suspension was added to each sample 
undergoing immunoprecipitation.
2.2.1.14.4 Immunoprecipitation
Nuclear extracts were incubated with ^/2q V°1 °f 
polyclonal antiserum (Section 2.2.1.12) for 10 min at 37°C, then 
at RT for 1 h. The volume was adjusted to 100 pi with TKM buffer 
and incubated at RT for 15 min. 50pl of Pansorbin suspension was 
then added to each sample. Incubation was at RT for 2 h. The 
samples were centrifuged at 13000 rpm for 5 min and the supernatant 
discarded. The pellets were washed X 3 in TKM buffer and X 1 in 
TKM/Triton X-100 buffer. The preparations were centrifuged as above 
and the pellets were redissolved in 20 pi SDS gel sample buffer.
The samples were heated to 100°C for 10 min, then centrifuged 
at 13000 rpm for 10 min. The supernatants were applied to 8.752
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acrylamide gels and electrophoresed as described in Section 
2.2.1.11. Following electrophoresis, the gel was subjected to 
fluorography (Section 2.2.2.5), dried and autoradiographed.
2.2.2 Limited Proteolysis of DNA Methylase Using Trypsin
2.2.2.1 Partial Proteolysis of DNA Methylase
Purified samples of DNA methylase (tRNA Sepharose 
fraction) were incubated at 37°C with a solution of trypsin 
prepared at lOOpg/ml in H20, to a final enzyme protein:trypsin 
ratio of 200:1. The reaction was stopped at the required time by 
the addition of equimolar concentrations of trypsin inhibitor and 
the samples stored on ice. Samples were assayed as described in 
Section 2.2.1.10.2.
2.2.2.2 Methylation of QX174RF DNA Using Proteolysed Enzyme
Ipg of 0X174RF DNA was incubated in a final volume of lOOpl 
containing 50pg BSA, 4.95 pCi S-adenosyl-L-[Methyl H^] methionine, 
and proteolysed DNA methylase in buffer M. The mixture was
incubated at 37°C for 4 h. A 10 pi aliquot was then removed into
490 pi stopper and assayed by the normal method. The remainder was 
added to 400 pi of a solution containing 3£j[ip-ainino salicylate,
0.125 M NaCl, 12 SDS, 2 mM EDTA, 52 (v/v) n-butanol. Protein was 
removed by extraction with 882 (v/v) phenol, 122 (v/v) m-cresol,
0.12 (v/v) 8 hydroxyquinoline and DNA was precipitated by addition 
;:pf.1/i0Vq( of 3M sodium aiefate pH 5.2 ahd2y1Cvolmries
The DNA was pelleted by centrifugation at 13000 rpm for 10 min at 4°C, and wihed with
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1 ml of cold ethanol. The DNA was repelleted as above and the 
ethanol drained. The pellet was allowed to dry at RT.
2.2.2.3 Restriction Enzyme Digest of Methylated 0X17A RF DNA
Methylated (J)X174 RF DNA (isolated as described in Section 
2.2.2.2) was re-suspended in 8 pi dH20. 10 units of REact buffer 
was added to each sample, followed by 10 units of the appropriate 
restriction enzyme. The solution was mixed briefly and incubated 
at 37°C for 3 h.
2.2.2.4 Agarose Gel Electrophoresis
Samples were prepared for electrophoresis by incubation 
with 5 pi of sample buffer at 68°C for 10 min. Samples were then 
applied directly to II (w/v) agarose slab gels and electrophoresed 
at 50 mA, for 3 h.
2.2.2.5 Fluorographic Detection of Radioactivity
; 1M11Sodium salicylate was prepared by the solution of salicylic 
acid in the presence of equimolar sodium hydroxide. The pH was 
adjusted to 6.0 and the gels were soaked in this solution for 1-2 h 
at RT. The gels were washed in dH20, dried and autoradiographed.
- 53 -
2.2.3 Production of Rat Monoclonal Antibodies
2.2.3.1 Immunisation
DA rats were injected subcutaneously with 100-200pg of 
purified DNA methylase (Fraction V). For the primary immunisation 
the enzyme was added to an equal volume of Freund’s complete adjuvant 
and mixed thoroughly before injection. A booster immunisation 
of lOOpg of DNA methylase mixed with an equal volume of Freund’s 
incomplete adjuvant was administered intraperitoneally three to 
four weeks later. A final boost containing 150pg of DNA methylase 
in PBS was given intravenously three days prior to the fusion.
2.2.3.2 Preparation of Spleen Lymphocytes
Rats were killed in ether and swabbed with 701 (v/v) 
ethanol. The spleen was dissected from the rat using sterile 
instruments and placed in a petri dish containing 5 ml of serum 
free medium. Subsequent procedures were carried out in a sterile 
hood. The spleen was gently scraped with two 21-G needles to 
release lymphocytes. The spleen capsule was then removed. Spleen 
cells were passed through sterile syringes fitted with 21-G needles 
(twice) and twice through 25-G needles. The cells were harvested 
by centrifugation at 800 g for 10 min, and the pellet washed in 
serum free medium. The cells were pelleted by centrifugation as
Q
above. A typical rat spleen yielded 10° cells.
2.2.3.3 Growth and Harvesting of Myeloma Cells
The Y3 cell line was grown in complete medium (Section 
2.1.10.7.1) containing 101 (v/v) foetal calf serum. Y3 cells were
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maintained in a state of rapid growth for two to three days before 
the fusion. Cells were harvested from the medium by centrifugation 
at 800 g for 10 min. The cells were washed in serum-free medium 
(Section 2.1.10.7.2) pelleted as above, and a sample count taken. 
Approximately 2-5 x 107 myeloma cells were required for fusing
Q
with 10 spleen cells.
2.2.3.4 Fusion of Myeloma and Spleen Cells
Q 7
Approximately 10 rat spleen cells were mixed with 4 x 10
myeloma cells in a conical tube and centrifuged at 800 g for 5 min.
The medium was removed and the cell pellet loosened by gentle 
tapping. 1 ml of 50Z PEG 1500 plus 5Z dimethyl sulphoxide was added 
over a period of 30 seconds, with continuous gentle agitation of 
the mixture for a further 60 seconds. 5 ml of serum-free medium
was then added over a period of 1-2 min, followed by a further 5 ml 
of the same medium. The cell suspension was centrifuged at 800. g 
for 10 min, washed with 10 ml of serum-free medium and centrifuged 
as above. The pellet was re-suspended in 5 ml of complete medium 
containing 20Z (v/v) foetal calf serum. Aliquots of 0.125 ml were 
dispensed to 36 x 1 ml tissue culture wells containing 0.4 ml of 
the same medium supplemented with 1 X HAT medium. The plating 
density was approximately 3 x 10° cells/well. The plates were 
sealed on two sides with adhesive tape and incubated at 37°C in 
a 41 C0£ incubator.
Controls included fused cells grown in medium without HAT, Y3 cells
grown in HAT medium and spleen cells grown in HAT medium.
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2.2.3.5 Feeding Hybridoma Cultures
Feeding the fused cells was carried out weekly, by 
removal of half the culture medium and replacement with complete 
medium containing 202 (v/v) foetal calf serum and 1 X HAT. When 
clones were established and growing rapidly the serum supplement 
of the medium was reduced to 102 (v/v).
2.2.3.6 Selection of Hybridomas in HAT Medium
Fused cells were maintained in HAT medium for four to five 
weeks. The hybrids were then cultured in HT medium for one week prior 
to growth in normal cell medium.
2.2.3.7 Detection of Positive Clones by ELISA
Three weeks after fusion, the supernatants of wells 
supporting cell growth were removed for assay, to identify clones 
secreting specific antibody.
96 well Dynatech microtitre plates were coated with a 
solution containing 6.25pg/ml purified DNA methylase (tRNA Sepharose 
fraction) in PBS, and incubated overnight at 4°C. The antigen was 
then shaken from the wells and the plates were immersed in PBS, 
then blotted dry on absorbent paper. The wells were blocked with 
a solution containing 10 mg/ml BSA in PBS for lh at RT. The plates 
were then washed X 3 in PBS containing 0.12 (v/v) Tween 20. 100 |il
aliquots of antiserum diluted in PBS containing 0.5 mg/ml BSA, or 
hybridoma supernatants were added to each well and the plate incubated 
for 2h at RT. The plate was washed as described above, and treated 
with lOOpl/well of a solution containing biotinylated sheep anti-rat
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whole Ig, diluted ^/100 PBS/1% (w/v) BSA. Incubation was for
lh at RT. After washing, each well was incubated with 100 p.1 of 
streptavidin biotinylated horse-radish peroxidase, diluted ^/4qo 
in PBS/1% (w/v) BSA for 30 min at RT. The plates were washed as 
above and 100 pi of OPD solution (Section 2.1.11.4) was added to 
each well. Incubation was at RT for 30 min in the dark. The 
reaction was stopped by the addition of 50 pi 4N I^SO^/well and 
the absorbance at 492 nm measured on a Titertek multiscanning 
spectrophotometer.
Controls included spleen cell supernatants and myeloma 
cell supernatants in place of hybridoma supernatants. Other 
controls involved the use of PBS in place of antigen, and minus 
antiserum (PBS supplemented with 0.5 mg/ml BSA).
2.2.3.8 Cloning Hybridomas
Hybridomas were cloned by limiting dilution. Cells were 
plated at theoretical densities of 60, 14.5, 3.5, 0.85, 0.21 cells/ 
well on 96 well tissue culture plates. Clones growing at estimated 
densities of 0.8 cells/well were recloned several times before 
assuming monoclonality.
2.2.3.9 Freezing Hybridomas
Aliquots of cells were added to 1 ml of a solution 
containing 90% (v/v) foetal calf serum and 10% (v/v) dime thy 1 s ulphoxide. 
Ampoules were frozen in a cryospeed freezing chamber and transferred 
to gaseous phase nitrogen (-120°C).
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2.2.3.10 Expansion of Clones
Hybridomas were expanded in vitro by transfer of cells to 
24 well tissue culture plates, followed by growth in 25 cm2, 80 cm2 
and 125 cm2 tissue culture flasks.
2.2.3.11 Purification of Immunoglobulin from Hybridoma Supernatants
2.2.3.11.1 Ammonium Sulphate Precipitation
50p£jof cell supernatant was harvested from culture flasks 
of hybridoma clones. The medium was centrifuged at 1000 g for 10 
min to pellet cells. The supernatant was removed and made to 482 
saturation with respect of ammonium sulphate. The solution was 
stirred on ice for a further 20 min and centrifuged at 14000 g for 
20 min. The supernatant was drained and the pellets stored at -20°C.
2.2.3.11.2 Fractionation on QAE Sephadex A-50
QAE Sephadex A-50 was swollen in PBS pH 6.5 for 36 h 
and degassed under vacuum before pouring into a 20 ml column. The 
column was washed with PBS pH 6.5 until the E280 value was < 0.01.
The ammonium sulphate pellet obtained in Section 2.2.3.11.1 was 
re-suspended in 1 ml of PBS pH 6.5 and applied to the column.
The sample was eluted with the same buffer at a flow rate of 1 ml/ 
minute, and 1 ml fractions were collected. Fractions were assayed 
for protein content by the method of Bradford (1976), and tested 
by ELISA to identify the peak immunoglobulin fractions.
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2.2.3.12 Titration of Immunoglobulin
Peak Immunoglobulin fractions (determined by ELISA assay) 
were titrated to quantitate the activity of the purified Ig. Serial 
dilutions of immunoglobulin were prepared in PBS containing 0.5 mg/ml 
BSA. Dilutions ranged from (^2 ~ 256* samples were tested
by ELISA (Section 2.2.3.7).
2.2.3.13 Neutralisation of DNA Hethylase Activity 
Using Purified Ig
3jig samples of purified DNA methylase (tRNA sepharose 
fraction) were incubated with various amounts of monoclonal immuno­
globulin in PBS, for 12 h at 4°C. The mixture was then incubated 
with the standard DNA methylase assay reagents for 1 h at 37°C, 
and assayed as described in Section 2.2.1.10.2-. Controls included 
Ig fractions isolated from unused culture medium.
2.2.3.14 Precipitation of DNA Methylase Using Purified Ig
3pg of purified DNA methylase (tRNA Sepharose fraction) 
were incubated with various amounts of monoclonal Ig in PBS, for 
12h at 4°C. The mixture was then centrifuged at 1000 g for 10 min 
to pellet immune complexes, and the supernatant assayed for 
methylase activity as described in Section 2.2.1.10.2.
Controls included Ig fractions isolated from unused culture medium.
2.2.3.15 Inununoblotting Using Monoclonal Antibodies 
and I * ^ -Labelled Protein A
Samples of purified DNA methylase (tRNA Sepharose 
fraction) were subjected to gel electrophoresis and transferred
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to a nitrocellulose membrane by the method of Ejj^hin_il979). The 
membrane was cut to separate single lanes of enzyme, and the strips 
placed in stoppered tubes. Non-specific sites were blocked by 
incubation with 3 ml of blotting buffer (Section 2.1.11.4) containing 
1Z (v/v) heat inactivated horse serum, for 5 min at RT. lOOpl of 
monoclonal antibody (peak QAE Sephadex-A50 fraction) was added to 
the mixture and the membrane incubated for a further 2h at RT with
constant gentle shaking. After washing to remove non-bound material,
125bound immunoglobulin was probed by incubation with labelled
protein A, for 2h at RT. The nitrocellulose strips were washed 
with blotting buffer, dried on 3 mm filter paper and autoradiographed.
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CHAPTER 3 : PURIFICATION OF DNA METHYLASE
Purification of DNA Methylase from
Mouse Krebs II Ascites Cells
3.1.1 Introduction
For the purposes of further characterisation of DNA 
methylase using polyclonal antiserum, and to obtain a supply of 
purified enzyme for the production of monoclonal antibodies, an 
enzyme purification strategy was devised. This was based on the 
method of Turnbull and Adams (1976) but with several significant 
modifications. In this section a detailed description and rationale 
of the purification described in Section 2.2.1 will be presented. 
Results of a typical purification are shown in Table 3.
3.1.2 The Choice of Mouse Ascites Tumour 
Cells as a Source of DNA Methylase
Nuclei isolated from rapidly dividing cells are known to 
show a greater level of incorporation of methyl groups into DNA than 
nuclei from resting cells (Adams et al, 1973; Tosi et al, 1972; 
Adams et al, 1974). Szyf et al (1985) have demonstrated that DNA 
methylase activity coincides with the activation of the cell’s 
replication machinery.
Mouse Krebs II ascites tumour cells were chosen as the 
enzyme source because of the high levels of DNA methylase present 
and the large number of cells obtainable, prohibitively expensive 
by tissue culture resources.
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3.1.3 Extraction of DNA Methylase from Ascites Nuclei 
Stirring nuclei in buffer M containing NaCl to a
final concentration of 0.2 M was found to be the optimum initial 
extraction method. Lower salt concentrations failed to release 
the bulk of enzyme activity from the nuclei and no significant 
increase in recovery was observed on extraction with a final 
concentration of 0.3 M NaCl. Concentrations of greater than 
0.3 M NaCl reduced recovery of enzyme by promoting aggregation 
of the nuclei.
Two consecutive 0.2 M NaCl extractions of the nuclei 
were carried out, releasing 88I of the enzyme activity into 
solution. The enzyme was recovered in the supernatant, following 
centrifugation of the nuclear suspension at 1200g for 10 minutes 
(Fraction II).
3.1.4 Phosphocellulose Ion Exchange Chromatography
3.1.4.1 Preparation of the Matrix
Phosphocellulose was prepared as a 50% (wet wt/vol) 
suspension in buffer M containing 0.2 M NaCl. Non-specific binding 
sites were blocked by treatment with II (w/v) BSA. The matrix was 
thoroughly washed and equilibrated before use.
3.1.4.2 Titration of Phosphocellulose
To determine the optimum amount of phosphocellulose 
required to bind DNA methylase recovered in Fraction II, varying
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amounts of phosphocellulose suspension, ranging from 8 ml to 36 ml, 
were mixed with aliquots of Fraction II. The samples were 
subsequently treated as described in Section 2.2.1.5. Following 
elution with buffer M containing 0.5 M NaCl, the samples were 
assayed for DNA methylase activity as described in Section 
2 .2 .1.10.2 .
Figure 1 shows the results of phosphocellulose titration. 
Treatment with 12 ml of phosphocellulose suspension per 100 ml of 
Fraction II results in optimum recovery of enzyme activity.
3.1,A.3 Phosphocellulose Chromatography
Fraction II was treated with 12 ml phosphocellulose 
suspension/100 ml as described in Section 2.2.1.5. Greater than 
901 of the total activity was routinely recovered from the pooled 
batch elutions (Fraction III) with a 13-fold increase in specific 
activity over Fraction II.
3.1.5 Ammonium Sulphate Precipitation of DNA Methylase
Previous results (Turnbull and Adams, 1976) have shown 
that optimum precipitation of DNA methylase occurs at concentrations 
of 30Z - 60% saturation with ammonium sulphate, with negligible 
amounts of enzyme being precipitated at concentrations outwith these 
limits.
502 saturation with respect to ammonium sulphate was 
used to precipitate DNA methylase from Fraction III, prior to gel 
filtration on Sephacryl S300. The precipitate obtained was drained
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Varying amounts of phosphocellulose suspension were mixed 
with aliquots of Fraction II to give final values of 8 ml, 
12 ml, 24 ml, 30 ml and 36 ml of 50Z phosphocellulose 
suspension added per 100 ml of Fraction II. Following 
washing and subsequent elution with buffer M containing
0.5 M NaCl, optimum enzyme activity was recovered from 
the use of 12 ml of 50Z phosphocellulose suspension/100 ml 
of Fraction II.
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thoroughly to ensure complete removal of the supernatant and stored 
at -20°C until use.
3.1.6 Gel nitration of DNA Methylase on Sephacryl S300 
Sephacryl S300 was used as the gel filtration matrix.
Particles of size 600,000 M.W. are excluded from the beads.
Figure 2 shows the elution profile obtained following application 
of an ammonium sulphate precipitate redissolved in buffer M 
containing 0.2 M NaCl on a 380 ml Sephacryl S300 column, using the 
same buffer as eluant. The void volume of the column was 108 ml. 
Fractions eluting at 1.2 - 1.6 X void volume (1-30 - 164 ml) were 
pooled (Fraction IV). DNA methylase elutes as a single peak, after 
the major protein peak of the sample. Purification of 1527 fold 
over the nuclear suspension was achieved at this stage. However, 
only 422 of the activity applied to the column was recovered, 
although it is possible that some loss of activity occurred 
during the preceding ammonium sulphate precipitation.
3.1.7 Ammonium Sulphate Precipitation of Fraction IV
To reduce the volume of Fraction IV prior to affinity 
chromatography, the sample was made to 702 saturation with respect 
to ammonium sulphate. This level of saturation was chosen to 
ensure precipitation of all the DNA methylase activity from the 
sample.
3.1.8 Affinity Purification of DNA Methylase
Affinity purification of DNA methylase was undertaken to 
remove contaminating proteins of similar size and charge from the
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DNA methylase (Fraction III, ammonium sulphate precipitated) 
was subjected to gel filtration on Sephacryl S300 and eluted with 
buffer M containing 0.2 M NaCl. 4 ml fractions were collected 
and the absorbance at 280 nm monitored. DNA methylase activity 
was assayed for samples eluting between 1.2 - 1.6 X void volume,
i.e. 130 - 164 ml.
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preparation which had failed to be removed by the preceding steps. 
Several affinity matrices were considered: Heparin Sepharose
readily bound the enzyme in low salt conditions (0.2 M NaCl). 
However, purification on this matrix resulted in a loss of over 
80Z of the enzyme activity initially applied, presumably due to 
irreversible binding of the enzyme on the column.
An affinity column of anti-methylase polyclonal 
immunoglobulin cross-linked to CNBr Sepharose was prepared. DNA 
methylase bound to this matrix under conditions of 0.2 M NaCl.
Again, finding a suitable eluant proved difficult. Buffer M 
containing 0.25% (v/v) Triton X-100 plus 3.5 M MgCl£ failed to 
release enzyme activity. It seems likely that DNA methylase was 
either irreversibly cross-linked to the immunoglobulin matrix or 
the elution conditions may have adversely affected enzyme activity.
E. coli transfer RNA cross-linked to Sepharose provided 
a suitable affinity ligand for the binding and elution of DNA 
methylase.
3.1.9 Affinity Chromatography on tRNA Sepharose
1 ml of redissolved ammonium sulphate precipitate (Section 
3.1.7) was de-salted on a 19 ml column of Sephadex G50. The non­
retarded fraction containing the enzyme was pumped directly onto 
a 10 ml column of tRNA Sepharose at a flow rate of 10 ml/hr. The 
A280 of the sample eluting from G50 Sephadex was monitored using a 
Uvicord detector and chart recorder. Following application of the 
protein peak eluting from G50 Sephadex onto the tRNA column, this
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column was washed with 1 volume of buffer M. The enzyme was then 
eluted in buffer M containing 0.2 M NaCl and 1 ml fractions were 
collected and assayed. Figure 3 shows the A280 elution profile
of the sample from tRNA [jjppharose (Fraction V).
3.1.10 Overall Purification of DNA Methylase
from Mouse Ascites Nuclei
Table 3 shows a summary of data obtained from a typical 
DNA methylase purification. A final purification of 2080-fold 
over the nuclear suspension was achieved.
Figure 4 shows a Coomassie blue-stained gel of Fractions 
II-V. Adams et al (1979) reported the molecular weight of mouse 
ascites DNA methylase between 160 kD and 185 kD. The major bands 
present in tracks 5, 6, and 7 in Figure 4 correspond to 160 kD, 175
kD and 190 kD, although a number of other protein bands are also
visible.
Figure 5 shows the result of a Western blot probed with 
polyclonal antiserum (see Section 2.2.1.12) and illuminated with 
125I-labelled protein A. The antiserum selectively interacts 
with two protein bands corresponding to 190 kD and 160 kD.
The purified enzyme fraction visualised in track 1,
Figure 5 showing approximately equal amounts of the 190 kD 
and 160 kD forms of DNA methylase, showed considerably greater 
activity (>9X) than the purified enzyme shown in track 2,
Figure 5, in which the 160 kD form is predominant.
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Figure 3
ELUTION PROFILE OF DNA METHYLASE FROM tRNA SEPHAROSE
lm l samples
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DNA methylase (ammonium sulphate precipitate) was de-salted 
on a Sephadex G50 column with the non-bound fraction applied 
directly to a tRNA Sephadex column for affinity purification.
Samples 1 - 1 3  G50/tRNA Run through
14 - 22 tRNA Wash (Buffer M)
23 - 32 tRNA Elution (Buffer M + 0.2 M NaCl)
Fraction Activity (U/mg)
9 413
10 212
25 1089
26 2081
27 2461
28 2238
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TABLE 3
PURIFICATION OF DNA METHYLASE FROM 
MOUSE KREBS II ASCITES TUMOUR CELLS.
FRACTION TOTAL PROTEIN TOTAL ACTIVITY SPECIFIC ACTIVITY 
(mg) (Units) (Units/mg)
NUCLEAR
SUSPENSION 1 45170 45120 1
0.2M NaCl
NUCLEAR
EXTRACT
II 1155 39600 34
PHOSPHO­
CELLULOSE III 79 35640 451
SEPHACRYL
S300 IV 9.7 14820 1527
tRNA
SEPHAROSE V 0.49 1020 2082
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FIGURE 4
Coomassie Blue-stained SDS polyacrylamide gel electrophoresis 
patterns of fractions from various stages of DNA methylase 
purification.
Track Sample
1 Markers: 200 kD, 165 kD, 155 kD
2 Fraction II
3 Fraction III
4 Fraction IV
5 )
Individual 1 ml samples eluted from tRNA Sepharose
6 ) Track 5 - Fraction 25
6 - Fraction 26
7 ) 7 - Fraction 27
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FIGURE 5
Western blot of purified DNA methylase (peak fractions elutinj 
from tRNA Sepharose) probed with polyclonal antiserum and 1*^ ' 
labelled protein A.
Track Sample
1 DNA methylase (Fraction V) eluting from tRNA 
Sepharose (Fraction 25)
2 DNA methylase (Fraction V) eluting from tRNA 
Sepharose (Fraction 26)
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Figure 6
Figure 6 shows the titration by ELISA of polyclonal antiserum 
raised against DNA methylase (see Section 2.2.1.12). Serial 
dilutions of antiserum ranging from 1/100 - 1/25600 were 
prepared in PBS containing 0.5 mg/ml BSA. The control shows 
ELISA readings obtained using pre-immune serum.
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3.2 Immunoprecipitation of DNA Methylase
from House L929 Cells
To investigate the size of DNA methylase at different 
stages of cell growth, the enzyme was immunoprecipitated from mouse 
L929 cells. The cells were radiolabelled with ^S-[L] Methionine, 
and DNA methylase was immunoprecipitated from cell extracts using 
polyclonal antiserum and Pansorbin (Section 2.2.1.14). Cells were 
harvested 18 h and 48 h after labelling, to observe the size of 
the enzyme present at log phase growth (18 h) and to determine 
if degradation of high molecular weight enzyme occurred as cell 
growth declined (48 h). The fluorograph in Figure 7 shows that 
the polyclonal antiserum immunoprecipitates 2 high molecular weight 
bands of 190 kD and 160 kD corresponding to the reported size of 
mouse DNA methylase.
Pre-immune serum failed to precipitate these proteins.
No distinct difference is observed between the protein bands 
precipitated from cells after 18 h or 48 h and subsequent 
experiments to immunoprecipitate the enzyme from cells at various 
stages of cell growth also failed to reveal any substantial change 
in the size of the enzyme.
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FIGURE 7
Fluorograph of DNA methylase immunoprecipitated 
from mouse L929 cells.
Track Sample
1 ) 5 ul 18 h cells immunoprecipitated
2 ) 15 ul tt
3 ) 45 ul tt
4 ) 5 ul 48 h cells immunoprecipitated
5 ) 15 ul
5 ) 45 ul t!
7 ) 15 ul 18 h cells + pre-immune serum
8 ) 15 ul 48 h cells + pre-immune serum
9 ) 15 ul 18 h Minus Antiserum
10 ) 15 ul 48 h Minus Antiserum
11 Antiserum only
12 Pansorbin only
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CHAPTER 4 : LIMITED PROTEOLYSIS 
OF DNA METHYLASE
The Effect of Limited Proteolysis
on. DNA Methylase Activity
4.1.1 Introduction
Stimulation of de novo methylation of DNA following 
limited proteolysis of mouse ascites DNA methylase was first 
reported by Adams et al (1983). In this Section, further data 
will be presented on:
(a) The breakdown pattern of the enzyme during proteolysis.
(b) The effect of varying degrees of proteolysis on enzyme
activity.
(c) The assessment of CpG specificity of the enzyme following 
proteolysis.
4.1.2 Partial Proteolysis of DNA Methylase
Purified, or partially purified, samples of DNA methylase 
were treated with trypsin as described in Section 2.2.2.1. Figure 8 
shows a Western blot of paired untreated and trypsin-treated enzyme 
samples. The enzyme protein:trypsin ratio used in samples 2, 4, 6,
8 and 10 was 200:1. The incubation time with trypsin was 30 minutes 
at 37°C in each case. Partial proteolysis of DNA methylase with 
trypsin was found to result in the gradual breakdown of the enzyme 
with the loss of the 190 kD and 160 kD species of enzyme, and the 
subsequent appearance of lower molecular weight, immunologically 
cross-reacting polypeptides. An increase in the specific activity 
of enzyme samples shown in tracks 1 and 7 was found to occur 
following treatment with trypsin (tracks 2 and 8 respectively;
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FIGURE 8
Western blot of partially proteolysed DNA methylase.
Paired samples of untreated and trypsin-treated enzyme are shown: 
odd numbered lanes show untreated DNA methylase from Fraction IV 
(Track 1) and Fraction V (Tracks 3, 5, 7 and 9) of a standard DNA 
methylase purification. Even-numbered lanes show proteolysis of 
the sample in the preceding track. Approximately 20pg of each 
sample was subjected to SDS PAGE. The specific activity of each 
sample is given below:
Lane Sample Specific Activity (U/mg)
1 Fraction IV 464
2 Fraction IV Proteolysed 1401
3 Fraction V 25 2400
4 Fraction V 25 Proteolysed 1155
5 Fraction V 26 2059
6 Fraction V 26 Proteolysed 1967
7 Fraction V 27 1395
8 Fraction V 27 Proteolysed 2679
9 Fraction V 28 1904
10 Fraction V 28 Proteolysed 1406
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see Figure 8 Legend) while samples in tracks 3, 5 and 9 showed 
some decrease in specific activity following proteolysis (Tracks 4,
6 and 10 respectively). As each of the proteolysed samples shown 
in Figure 8 were subjected to 30 minutes incubation with trypsin, 
it seemed possible that despite the standard enzyme protein:trypsin 
ratio applied, the individual enzyme samples had undergone varying 
degrees of proteolysis during this time.
To further investigate the effect of limited proteolysis 
on enzyme activity, a time course of enzyme incubations with 
trypsin was carried out. Again, the final enzyme protein:trypsin 
ratio was 200:1. The mixture was incubated at 37°C and aliquots 
were removed after 1, 5, 10, 15, 20, 25, 30 and 40 minutes. The 
reaction was stopped by the addition of equimolar trypsin inhibitor. 
DNA methylase activity was assayed using native M. luteus DNA as 
the substrate. The size of the proteolysed enzyme was assessed 
immunologically, by Western blotting and probing with polyclonal 
antiserum and I^2^-labelled protein A, as described in Section 
2.2.1.13.
4.1.3 Stimulation of DNA Methylase Activity
Following Limited Proteolysis
Figure 9A shows a Western blot of DNA methylase following 
treatment with trypsin over a period of 1-40 minutes. The graph in 
Figure 9B shows corresponding enzyme activity over the same period.
The substantial increase in enzyme activity initially 
observed is followed by a gradual drop in enzyme activity to below
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FIGURE 9A
Western blot of DNA methylase subjected to partial proteolysis 
with trypsin over a period of 1-40 min.
Lane Incubation Time with Trypsin
1 - (untreated DNA methylase)
2 1 min
3 5 min
4 10 min
5 15 min
6 20 min
7 25 min
8 30 min
9 40 min
FIGURE 9B
Specific activity of partially proteolysed DNA methylase 
using native M. luteus DNA as the substrate. Activities 
given correspond to the samples shown in Figure 7A.
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the level of the control: After a 1 minute incubation of DNA
methylase with trypsin, the specific activity of the enzyme on 
native DNA is seen to increase by greater than three fold, rising 
to a four fold increase after 5 minutes and a six fold increase 
after 10 minutes’ incubation. Between 15 and 20 minutes, enzyme 
activity begins to decline and thereafter the activity measured 
is considerably lower than that of the untreated enzyme. This 
is presumably due to more extensive proteolysis of the enzyme, 
causing a break in molecular configuration.
From the autoradiograph in Figure 9A, the corresponding 
degree of breakdown of DNA methylase following SDS polyacrylamide 
gel electrophoresis and Western blotting is shown. After incubation 
with trypsin for 1 minute, the 190 kD band present in the untreated 
enzyme sample is no longer visible, and after 5 minutes the 160 kD 
protein band has also been replaced by a series of lower molecular 
weight polypeptides, with bands notably evident at 100 kD and 24 kD. 
After 30 minutes’ incubation, the 100 kD band is seen to diminish 
with the predominant species now the 24 kD polypeptide band.
The degradation pattern of proteolysed DNA methylase 
observed upon SDS gel electrophoresis may not reflect the true 
state of the enzyme as it undergoes limited proteolysis: it
is likely that treatment with trypsin, introducing nicks into 
the amino acid sequence, does not immediately cause the enzyme 
to dissociate into discrete fragments. The initial effect of 
introducing breaks in the polypeptide chain is likely to be a 
more general loosening of the domain structure of the enzyme.
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The loss or spatial distancing of a regulatory domain (possibly 
for CpG recognition, or for the recognition of hemi-methylated 
sites in DNA) may account for the increased level of DNA methylase 
activity observed following limited proteolysis. The structure 
of DNA methylase may therefore initially remain relatively intact 
in vitro, although the conditions of SDS PAGE would suffice to 
cause dissociation of the partially proteolysed enzyme. As 
proteolysis proceeds and a large number of breaks are introduced, 
more extensive breakdown of the enzyme may occur in vitro. The 
complete dissociation of enzymatic domains may account for the 
negligible levels of enzyme activity observed following prolonged 
exposure of DNA methylase to trypsin.
4.1.4 Specificity of DNA Methylase Following
Partial Proteolysis
One possible explanation for the increase in activity of 
the proteolysed enzyme is that it may be less stringent with regard 
to the CpG site specificity characteristic of the native enzyme.
To investigate this further, 0X174 R.F. DNA was methylated using 
untreated and trypsin-treated DNA methylase (Section 2.2.2.2). 
Controls included the same reaction procedure carried out in
O
the absence of S-adenosyl-L-[Methyl- H] methionine. Following 
methylation, the DNA was isolated and digested with methyl 
sensitive restriction enzymes. Table 4 describes the properties 
of the restriction enzymes used:
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TABLE 4
Summary of Restriction Enzyme Properties
Enzyme Recognition
Site
Recognition
Blocked
No. of Sites in 
0X174 RF DNA
Hpa II CCGG CmCGG 5
Msp I CCGG mCCGG 5
Alu I AGCT AGmCT 24
Eco RII CCA/TGG CmCA/TGG 2
The use of these enzymes allows identification of 5-m Cytosine 
residues in the dinucleotide sequences CC, CA, CT as well as CG. 
Following restriction enzyme digestion of the DNA, fragments were 
separated by agarose gel electrophoresis.
4.1.5 Methylation and Restriction Enzyme 
Digestion of 0X174 RF DNA
Bacteriophage 0X174 RF DNA was methylated and digested 
with restriction enzymes as described in Section 2.2.2. Following 
assay (see Section 2.2.2.2) the percentage methylation was 
calculated by:
p Moles 5-mC incorporated
________________________  X 100
p Moles CpG in 0X174 DNA
where 0X174 RF DNA contains 15 p Moles of CpG. Methylation of 
the DNA with native DNA methylase proved difficult as the DNA was
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frequently degraded, or otherwise undetectable, following restriction 
digestion and agarose gel electrophoresis. This effect may have been 
due to the presence of exogenous nucleases in the enzyme preparation, 
despite the presence of 1 mM EDTA (known to inhibit many nucleases) 
during preparation and storage of the enzyme. The presence of active 
nucleases could cause substantial degradation of DNA during the 4 h 
incubation with DNA methylase. No such degradation is observed upon 
methylation of DNA with trypsin-treated enzyme, indicating perhaps 
that trypsin inactivates nuclease activity. This in itself could 
lead to an apparent increase in methylase activity.
An alternative explanation is that enzyme-DNA aggregates 
form upon incubation of DNA with native DNA methylase, with 
subsequent loss of DNA following phenol extraction. Proteolysis of 
the incubation mix after the addition of SDS but prior to isolation 
of DNA, should cause dissociation of such complexes and resolve this 
possibility.
4.1.6 Restriction Digest Analysis of Methylated fl)X174 RF DNA
Figures 10, 11 and 12 show the restriction patterns 
obtained following electrophoresis of DNA digested with Alu I and 
Eco RII (Figure 10), and Hpa II and Msp I (Figures 11 and 12).
No difference in the restriction pattern could be detected between 
methylated and unmethylated DNA digested with Alu I, indicating 
that methylation of CpT does not occur to a measurable extent when 
the overall level of DNA methylation is 13Z.
Eco RII consistently failed to cleave either methylated
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FIGURE 10
Restriction of 0X174 RF DNA by Alu I and Eco RII.
Track
1 Methylated 0X174 RF DNA digested with Alu I.
2 Unmethylated 0X174 RF DNA digested with Alu I.
3 Methylated (J)X174 RF DNA digested with Eco RII.
4 Unmethylated 0X174 RF DNA digested with Eco RII.
Digestion of 0X174 RF DNA methylated to 131, with the 
restriction enzymes Alu I and Eco RII.
Tracks 1 and 2 show a comparison of DNA methylated using 
partially proteolysed DNA methylase (Track 1) and with the 
same enzyme in the absence of S-Ado Met (Track 2). The 
restriction pattern obtained upon digestion of DNA with 
Alu I is the same in each case, indicating no substantial 
protection of CpT sites by methylation.
Tracks 3 and 4 illustrate the inability of Eco RII to 
cleave methylated DNA (Track 3) or DNA mock-methylated in 
the absence of S-Ado-Met (Track 4), probably due to inherent 
methylation of these sites during propagation of the phage 
in a dcm+ host strain of E. coli.
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or unmethylated DNA: it is therefore not possible at this stage to
exclude the occurrence of CpA methylation. Resistance of 0X174 RF 
DNA to restriction with Eco RII may be due to dcm methylation of the 
phage DNA. Self-methylation is a mechanism by which bacteriophage 
can overcome the restriction modification system of the infected 
host cell. Dam methylation refers to methylation of Adenine in 
the sequence GATC, while dcm methylation results in modification 
of Cytosine in the sequence CC(A/T)GG, which is the recognition 
site for restriction with Eco RII.
Figures 11 and 12 show the restriction pattern obtained 
following digestion of 0X174 RF DNA methylated to 5Z and 272 
respectively, using partially proteolysed DNA methylase (Tracks 1 
and 2) and incubated with the same enzyme in the absence of S-Ado 
Met (Tracks 3 and 4). Tracks 1 and 3 show digestion with Hpa II, 
and Tracks 3 and 4 show digestion with Msp I. In Figure 11, some 
inhibition of Hpa II digestion (Track 1) is evident in comparison 
with the restriction pattern in the unmethylated control (Track 3). 
Several extra bands are visible in Track 1, indicating that 
methylation of CpG has occurred, blocking the action of Hpa II on 
its target site. No inhibition of Msp I is observed in Track 2 
when compared with the control (Track 4).
In Figure 12, inhibition of Hpa II is again observed 
(Track 1). In addition, the restriction pattern of Msp 1 on 
methylated DNA (Track 2) appears to correspond closely to that 
of methylated DNA cleaved with Hpa II. However, it is possible 
that on this occasion Msp I failed to cut for reasons other than
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FIGURE 11
Restriction, enzyme digestion of methylated and unmethylated 
0X174 RF DNA.
Track 1 : Hpa II digestion of 0X174 RF DNA methylated to 52.
Track 2 : Msp I digestion of 0X174 RF DNA methylated to 52.
Track 3 : Hpa II digestion of unmethylated 0X174 RF DNA.
Track 4 : Msp I digestion of unmethylated 0X174 RF DNA.
Some inhibition of Hpa II digestion is evident in Track 1, 
indicating CpG methylation. No inhibition of Msp 1 is 
evident in Track 2.
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FIGURE 12
Restriction enzyme digestion of methylated and unmethylated 
0X174 RF DNA.
Track 1 : Hpa II digestion of 0X174 RF DNA methylated to 211.
Track 2 : Msp I digestion of 0X174 RF DNA methylated to 211.
Track 3 : Hpa II digestion of unmethylated 0X174 RF DNA.
Track 4 : Msp I digestion of unmethylated 0X174 RF DNA.
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methylation of the 51 C in its recognition sequence, as the control 
digestion with unmethylated DNA also shows considerable failure 
to cleave (Track 4).
4.1.7 Fluorography of Methylated 0X174 RF DNA
Figures 13 and 14 show fluorographs corresponding to 
the restriction digests show in Figures 11 and 12. A comparison 
of these fluorographs showing the restriction patterns of DNA 
methylated to 5% (Figure 13) and 21% (Figure 14) indicates that 
there is a greater level of inhibition of Hpa II action in the 
latter case. While there also appears to be some inhibition of 
Msp I (Track 2) it is not possible to correlate this solely to 
methylation of CpG sites in view of Figure 12 (Track 4). The 
specificity of the proteolysed enzyme for CpC sites therefore 
remains undetermined.
The difficulty of methylating 0X174 DNA to a level 
of greater than 302 presents problems in the interpretation of 
results. It is possible that the proteolysed enzyme retains a 
sequence preference for cytosine residues in the dinucleotide CpG 
and methylates other sites at a lower frequency, undetectable at 
low overall levels of DNA methylation.
The nature of the proteolysed enzyme "activation" 
observed is unresolved at this stage. Further studies on the DNA 
recognition site of the proteolysed enzyme are required before it 
will be possible to state with certainty that the increased activity 
is not due to a loss of DNA site specificity by the enzyme.
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FIGURE 13
Fluorograph of the restriction digests shown in Figure 11.
Following electrophoresis, agarose gels were incubated in 1 M 
Salicylic acid/1 M NaOH pH 6, for 1-2 h at RT. The gels were 
then washed in dH£0, dried and autoradiographed.
Track 1 : Hpa II digestion of 0X174 RF DNA methylated to 5Z. 
Track 2 : Msp I digestion of 0X174 RF DNA methylated to 52.
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FIGURE 14
Fluorograph of the restriction enzyme digests shown in 
Figure 12.
Following electrophoresis, agarose, gels were incubated in 1 M 
Salicylic acid/1 M NaCH pH 6, for 1-2 h at RT. The gels were 
then washed in dH20, dried and autoradiographed.
Track 1 : Hpa II digestion of 0X174 RF DNA methylated to 272. 
Track 2 : Msp I digestion of 0X174 RF DNA methylated to 272.
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CHAPTER 5 : PRODUCTION AND PRELIMINARY 
CHARACTERISATION OF RAT MONOCLONAL 
ANTIBODIES AGAINST DNA METHYLASE
Chapter 5 : Production and Preliminary Characterisation of
Rat Monoclonal Antibodies Against DNA Methylase
5.1 Introduction
The task of preparing monoclonal antibodies against DNA 
methylase was undertaken to provide a more precise immunological 
tool to study [characterisation of Ithe enzyme in greater detail. In 
this section the production techniques used to generate monoclonal 
antibodies, and details of the preliminary characerisation of 
antibody-secreting hybrid clones will be discussed.
5.2 Choice of Animals and Cell Lines
The rat system was chosen primarily because of the nature 
of the antigen - in these studies, mouse DNA methylase. In general, 
a greater response is elicited in the host by a foreign antigen.
DA rats were used as recipients for the antigen, and the rat 
myeloma line Y3.Ag 1.2.3 (Y3) was used as the fusion partner for 
spleen cells in all fusion experiments. The Y3 line is derived 
from the LOU/C strain of rats (Bazin et al, 1973). Y3.Ag 1.2.3 
is an azaguanine resistant derivative of the myeloma R210.RCY3, and 
secretes kappa light immunoglobulin chains. Azaguanine resistance 
is selected as a means of isolating HPRT- cells. 8-azaguanine is 
a cytotoxic base analogue which is incorporated into DNA via HPRT. 
Cells in which only the main purine biosynthetic pathway is 
functional and which therefore lack HPRT can continue to grow in 
the presence of 8-azaguanine, while cells operating both the main 
and salvage synthetic pathways will die.
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5.3 Procedure for the Isolation of Monoclonal Antibodies
In the development of a protocol for the production of 
monoclonal antibodies against DNA methylase, several variations of 
procedures were considered to establish optimum fusion conditions. 
Davidson et al (1976) and Klebe and Mancuso (1981) have reported 
that most successful fusions are performed using polyethylene 
glycol (PEG) in the molecular weight range 600 - 6000. In these 
studies 502 PEG 1500 supplied by Boehringer in 75 mM Hepes buffer 
pH 7.5 was used as the fusing agent. The reported optimum pH for 
fusions lies between 7.55 - 8.20 (Klebe, 1981) while 75 mM Hepes 
is thought to be the most satisfactory buffer (Sharon, 1980). DMSO 
is reported to enhance fusion frequency (St Groth and Scheidegger, 
1980). In a comparative study of fusions carried out using PEG 1500 
in the absence and the presence of 52 DMSO, it was found that a 
greater proportion of fused cells resulted from the latter approach.
As PEG is toxic to cells, the amount of PEG 1500 used 
and the length of time it remained in contact with the cells proved 
critical. 1 ml of PEG 1500 per 1.5 x 10® cells (typical fusion) 
proved sufficient for a successful fusion. Incubation times of 
greater than 90 seconds frequently proved fatal to most of the 
cells.
The fusion procedure used to generate hybridomas is 
given in Section 2.2.3.4.
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5.4 Hybridoma Techniques
5.4.1 Selection of Fused Cells in HAT Medium
To eliminate non-fused myeloma cells from the fusion 
mixture, selective pressure against the parent myeloma (Y3.Ag 1.2.3) 
was introduced by maintenance of the cells in medium containing 
Hypoxanthine, Aminopterin and Thymidine (HAT medium). The absence 
of the enzyme Hypoxanthine-Guanine phosphoribosyl transferase 
(HPRT) from the parent myeloma line forms the basis for selection 
of hybridomas in HAT medium. Aminopterin, a folic acid antagonist, 
blocks the main biosynthetic pathway of purine and pyrimidine 
synthesis.
Salvage pathways by which exogenous nucleosides are 
utilised for synthesis of deoxynucleotide triphosphates, involve 
the enzyme Thymidine Kinase (TK) in the pyrimidine pathways 
and HPRT in the purine pathway. TK catalyses the conversion of 
exogenous thymidine to dTMP, subsequently phosphorylated to dTTP.
In the purine salvage pathway the conversion of hypoxanthine and 
guanine to IMP, the precursor of both AMP and GMP, is dependent 
on the enzyme HPRT. Cells lacking this enzyme are unable to grow 
in HAT medium as both metabolic pathways for purine biosynthesis 
are blocked. Normal spleen cells remain viable in culture for 
only a few days, hence only fused cells possessing HPRT activity 
and the ability to divide indefinitely will grow.
It is essential to eliminate unfused myeloma cells 
from the mixed culture as soon as possible, as rapidly growing
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myeloma cells can easily dominate cultures containing initially 
slow growing hybridomas.
5.4.2 Maintenance of Hybridoma Cultures
In general, colonies of fused cells were visible 7-10 
days after the fusion, although all plates were monitored for 
several weeks to detect initially slow-growing hybridomas. The 
cells were maintained in HAT medium for 4-5 weeks, before transfer 
to medium containing HT for one week to ensure the complete removal 
of aminopterin. Following this the cells were maintained in normal 
growth medium.
Approximately 3 weeks after the fusion, when hybrid 
cells had grown to near confluency, supernatants were removed from 
the wells and tested for specific antibody content by ELISA assay. 
Positive wells were subcloned several times and re-tested by ELISA. 
At each stage of cloning, aliquots of cells were frozen to safe­
guard against loss of secretion of specific antibody, or culture 
contamination. Occasionally, subclones initially established to 
be positive with regard to secretion of specific antibody were 
later found to be indistinguishable from control supernatants 
when tested by ELISA, indicating that some reversion did occur.
In general, however, cells which were positive on the parent 
plate retained this identity throughout cloning.
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5.5 Specificity of the Monoclonal Antibodies
5.5.1 Tests for Monoclonal Antibody Specificity
From a large number of established clones, 6 hybridomas 
were selected for characterisation on the basis of their rapid 
growth and positive assay by ELISA. Several tests were selected 
to determine whether the antibodies produced were specifically 
directed against DNA methylase, namely:
(A) Inhibition of enzyme activity.
(B) Immune precipitation of the enzyme.
(C) Immunodetection of DNA methylase on Western blots.
Initially, crude supernatants from hybrid clones were 
used in these tests and appeared to cause inhibition of enzyme 
activity. However, controls of unfused myeloma supernatants gave 
a similar result, indicating that some component in the cell medium 
was the most likely cause of this observation. It therefore proved 
necessary to isolate immunoglobulins from the cell supernatants to 
use in these tests.
Purification of monoclonal immunoglobulin from supernatants 
is described in Section 2.2.3.11. Following precipitation in ammonium 
sulphate and fractionation on QAE Sephadex-A50, samples were assayed 
by ELISA to determine the peak immunoglobulin containing fraction. 
Immunoglobulins from 6 hybrid clones: 4B, 4E, 4H, 5G, 6E, 8E were 
prepared in this way. Figure 15 shows SDS gel electrophoresis of 
the QAE Sephadex fractionation of immunoglobulin 4B.
- 95 -
FIGURE 15
Coomassie Stained Gel of Monoclonal Immunoglobulin 4B, 
fractionated from the hybridoma cell supernatant.
Track Sample
1 Markers: 185 kD, 95 kD, 68 kD
ml Eluted from QAE
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7
8 
9
10 
11 
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13
14
15
16
17
18
19
20 
21
Tracks 2-17 show 1 ml samples collected from QAE Sephadex. 
Optimum activity (as measured by ELISA assay) was contained 
in the sample shown in Track 10.
2
3
4
5
6
7
8 
9
10
11
12
13
14
15
16 
17
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5.5.2 Fractionation and Titration of Monoclonal
Immunoglobulins
Figure 16 shows the elution profile of purified 
immunoglobulins from cell supernatants following fractionation 
on QAE Sephadex A50. Individual 1 ml fractions collected were 
tested by ELISA assay (absorbance measured at 492 nm) and the 
protein content was measured by the method of Bradford (1976).
As a control, immunoglobulin from unused complete medium 
containing 101 (v/v) FCS was isolated and assayed by the same 
procedure. The maximum ELISA reading of the control sample 
was found to be 0.2, while immunoglobulins isolated from hybrid 
clones show maximum values ranging from 0.50 - 0.84. Maximum 
Ig activity (as measured by ELISA assay) eluted before the major 
protein peak in each sample.
To give an approximate measure of the degree of antibody 
affinity for the enzyme, peak immunoglobulin fractions were titrated. 
Antibody dilutions ranged from 1/2 - 1/128. Figure 17 shows the 
titration of immunoglobulin from samples 8E, 4E, 4H and 6E.
5.5.3 The Use of Monoclonal Immunoglobulin to
Neutralise DNA Methylase Activity
Section 2.2.3.13 describes the procedure used to 
determine whether monoclonal immunoglobulins can inactivate DNA 
methylase activity. Varying amounts of monoclonal antibody were 
incubated with DNA methylase to allow binding of specific antibody 
to the enzyme. The mixture was then assayed as described in 
Section 2.2.1.10.2. Controls included enzyme incubated with
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FIGURE 16
Elution of Monoclonal Immunoglobulin from QAE Sephadex A-50.
Graphs show the degree of interaction of the fractionated 
monoclonal immunoglobulin with DNA methylase as measured by 
ELISA assay (A492 nm), and the corresponding protein content 
of the samples.
Graph Immunoglobulin
A 4H
B 5G
C 4E
D 6E
E 4B
F FCS Ig
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FIGURE 17
Titration of Monoclonal Immunoglobulin.
To determine the affinity of the purified immunoglobulin for 
DNA methylase, samples showing maximum Ig activity (as measured 
by ELISA, see Figure 16) were titrated.
Graphs in Figure 17 show ELISA results of the peak immunoglobulin 
fraction at dilutions ranging from 1/2 to 1/128 (N = Neat, 
undiluted Ig).
Ig isolated from unused cell culture medium containing foetal 
calf serum was used as the control. The titres of the purified 
immunoglobulin fractions fell between Ig dilutions of 1/32 and 
1/64.
Figure Sample
A Titration of Ig 8E
B Titration of Ig 4E
C Titration of Ig 4H
D Titration of Ig 6E
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immunoglobulin isolated from unused culture medium and enzyme 
incubated in PBS prior to assay.
Figure 18 show the enzyme assay results following 
preincubation with various immunoglobulins. No marked inhibition 
of enzyme activity was detected. In some cases (namely Figure 18 B, 
C and D) stimulation of enzyme activity was observed although 
presumably this is not immunoglobulin related.
5.5.4 Precipitation of DNA Methylase by
Monoclonal Immunoglobulin
Precipitation of DNA methylase by purified monoclonal 
immunoglobulins is described in Section 2.2.3.14. DNA methylase 
was pre-incubated with varying amounts of immunoglobulin to allow 
formation of an immune complex. The mixture was centrifuged and the 
supernatant assayed in a standard DNA methylase assay. Figure 19 
show the assay results obtained. Few samples showed values below 
the level of the control, indicating that the enzyme did not appear 
to have formed a precipitable complex with the immunoglobulin, and 
again there appears to be stimulation of enzyme activity in some 
cases.
The failure either to precipitate the enzyme from solution 
using monoclonal immunoglobulins, or to inactivate DNA methylase 
activity, will be discussed in Chapter 6.
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FIGURE 18
Inhibition of DNA Methylase by Monoclonal Immunoglobulin.
Varying amounts of monoclonal immunoglobulin were pre-incubated 
with DNA methylase for 12 h at 4°C to allow binding of specific 
antibody to the enzyme. The enzyme - Ig samples were then assayed 
as described in Section 2.2.1.10.2. The control sample "C" on 
each graph shows enzyme activity following pre-incubation of DNA 
methylase with PBS prior to assay.
Graph
A Enzyme pre-incubation with Ig 4H
B Enzyme pre-incubation with Ig 4B
C Enzyme pre-incubation with Ig 4E
D Enzyme pre-incubation with Ig 5G
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INHIBITION OF DNA METHYLASE BY MONOCLONAL IMMUNOGLOBULIN
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FIGURE 19
Precipitation of DNA Methylase by Monoclonal Immunoglobulin.
DNA methylase was pre-incubated with purified monoclonal Ig to 
allow formation of immune complexes. The mixture was centrifuged 
and the supernatant was assayed for enzyme activity as described 
in Section 2.2.1.10.2. The control sample "C" on graph B.j > J 
shows the activity of enzyme pre-incubated in.PBS.
A and B,This control sample refers to the experiments shown in graphs
Graph
A
B
Immunoprecipitation of enzyme by Ig 4B 
Immunoprecipitation of enzyme by Ig 4H
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5.5.5 Immunodetection of DNA Methylase by
Monoclonal Immunoglobulin
Monoclonal immunoglobulins were used to probe DNA 
methylase hybridised on a nitrocellulose membrane (Section 
2.2.3.15). Attempts to illuminate the enzyme on the membrane 
using purified immunoglobulin and I^^-labelled protein A were 
unsuccessful. It is unclear whether this was due to a low 
specificity of the antibody molecules for the denatured protein, 
the absence of a sufficient number of antibody molecules to 
react with the enzyme or a lack of specificity of the antibodies 
for DNA methylase. The implications of this result will be 
discussed at length in Section 6.6.
Since protein A interacts with only a minor subclass of rat IgG species, it is possible that an 
alternative detection method will prove succesful in identifying interactions of DNA methylase on 
Western blots with specific monoclonal antibodies . Rabbit anti-rat whole Ig can be used as a linker 
molecule, creating a sandwich of monoclonal Ig - anti rat Ig -I125 protein A. By this means a wider 
range of monoclonal antibody species may be identified, as anti-rat whole Ig interacts with the four 
rat IgG subclasses and IgM. .
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CHAPTER 6 : DISCUSSION
6.1 Introduction
Since the discovery of the enzymatic methylation of DNA by 
Burdon etal. (1967) various studies have been undertaken to purify 
and characterise DNA methylase from a wide range of mammalian 
sources. The difficulties of this task are reflected in the fact 
that, to date, many structural features of the enzyme and its mode 
of catalysis remain incompletely characterised. The strategy 
underlying the use of antibodies in the present work is outlined 
in Section 1.5.
6.2 Factors Influencing Antibody-Antigen Interactions
Interactions between an antibody and a protein antigen
occur subject to a variety of factors influencing the degree of 
complementarity between the two molecules: The molecular shape of
the interacting molecules, surface charges, hydrogen bonding and 
hydrophilic/hydrophobic interactions all contribute to the potential 
for antibody-antigen binding. Mobility and accessibility of surface 
determinants may influence the antigenicity of the molecule, although 
it is likely that all accessible regions will be potentially 
antigenic. Antigenic determinants on protein antigens are surface 
structures which may be formed by contiguous or non-contiguous amino 
acid sequences. Antibody-antigen interactions may effect significant 
structural changes in the antibody or antigen, or there may be no 
detectable alteration, as both flexible and rigid structures can be 
antigenic. The mechanism of antibody-antigen interaction can take 
the form of a rigid "lock and key" mechanism, where the antibody and 
antigen surfaces complement one another prior to binding (Fischer,
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1894), illustrated in the binding of the D1.3 Fab lysozyme complex 
(Amit et al, 1986). Alternatively, an "induced fit" mechanism may 
operate, whereby some degree of conformational change in either or 
both of the interacting molecules contributes to the final binding 
configuration. For antibodies this may involve movement of the 
hypervariable loops or possibly major movement of the two variable 
domains of the antibody relative to one another (Davies et al, 1988).
Some significant conformational change in the antigen is 
also thought to accompany binding (Getzoff et al, 1987, Geysen et 
al, 1987). It seems likely that some conformational changes in 
both antibody and antigen molecules will occur as their surfaces 
are brought into contact. The antibody combining site is formed 
by the juxtaposition of the Vg and domains which are joined 
by non-covalent forces. Interaction of these sites with antigen 
may result in the positioning of Vy relative to such that 
the complementarity of the antibody for the antigen is increased.
6.3 Antibodies as Probes
The decision to use both polyclonal and monoclonal 
antibodies as probes to study DNA methylase was based on the premise 
that each type of antiserum has distinct advantages for the detection 
and analysis of antigen under different in vitro and in vivo 
conditions. While some degree of non-specific interactions may occur 
using polyclonal antiserum, the specificity of monoclonal antibodies 
for single determinants on the antigen may prove impracticable for 
detection by some screening methods, with polyclonal antibodies
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providing a more comprehensive signal. In other cases the 
specificity of monoclonal antibodies for antigen can be used to 
advantage in the precise detection of antigenic determinants, 
without interference from non-specific antibody-antigen 
interactions, often inevitable using polyclonal antiserum.
Occasionally, unexpected cross reactivity of monoclonal 
antibodies can occur (Lane et al, 1982). This may be due to the 
detection of structurally similar epitopes in two antigens, or to 
multispecificity of the antibody combining site, enabling it to 
stably bind structurally unrelated antigens through different 
bonding interactions.
Relatively high yields (up to lmg/ml) of antibody can be 
obtained from polyclonal antiserum and used to detect antigen by 
conventional immunological assays, e.g. ELISA, immunoprecipitation, 
Western blotting, radioimmunoassay and immunocytochemistry. However, 
despite extensive purification of the antigen prior to immunisation, 
antibodies against minor contaminants may still arise, resulting 
in some non-specific cross reactions by the antiserum. Highly 
immunogenic contaminants may result in non-specific antibodies 
outnumbering the required specific antibodies.
6.4 Comparison of Monoclonal and Polyclonal
Antibody Interactions
Polyclonal antiserum, by definition, consists of a 
heterogeneous population of hundreds or thousands of clonal products
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which are capable of interacting with many or all of the antigenic 
determinants accessible on the antigen surface (Benjamin et al,
1984). Binding conditions for polyclonal antibodies are generally 
effective over a broad range of pH (4-9) and salt concentrations 
(0-1M NaCl). Within the population, antibodies differ widely in 
their affinity for the target antigen. In contrast, monoclonal 
antibodies consist of an homogenous clonal product, with antibodies 
usually binding at a single unique site on the target antigen. A 
monoclonal antibody has a uniform affinity for the antigen. The 
range of conditions over which monoclonal antibodies are operative 
is often more discrete than that described for polyclonal antibodies, 
though it may vary from one monoclonal antibody population to another.
The reactivity of immune serum generated against native 
protein antigen is often much weaker when tested on the denatured 
protein (Arnon, 1973) although in general^ polyclonal antiserum 
contains some antibodies which can recognise the denatured protein.
The formation of three dimensional lattice structures, formed by 
cross-linking between polyclonal antibodies and antigen does not 
generally occur on incubation of antigen with a single species 
of monoclonal antibody (with the exception of antigen molecules 
exhibiting two or more identical binding sites). In addition, 
because the antigen is bound by interaction to only one monoclonal 
antibody, the affinity of the antibody for antigen is critical. 
Monoclonal antibodies with affinities less than 107 mol-1 may prove 
to be unsuccessful in immunoprecipitation of antigen. Screening 
techniques for hybridomas will detect antibodies with an affinity 
of 10® mol"^ or greater (Lane, 1982) therefore not all monoclonals
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will be suitable for use in immunoprecipitation assays.
Cross-linking and immunoprecipitation of antigen can 
usually only be achieved using two or more species of monoclonal 
antibodies. The use of pooled monoclonal antibodies incorporates 
the best properties of polyclonal and individual monoclonal 
antibodies, combining a high degree of specificity with the ability 
to form stable immune complexes. The use of selectively pooled 
combinations of monoclonal antibodies is likely to provide the 
best reagent for immunoprecipitation of antigen.
6.5 Interaction of Monoclonal Antibodies with DNA Methylase
The failure to precipitate DNA methylase using a single 
species of monoclonal antibody most likely reflects the specificity 
of the antibodies for single non-repetitive determinants on the 
enzyme. Neutralisation of enzyme activity by a single species of 
monoclonal antibody would only be expected to occur in cases where 
the antibody was directed against an epitope near the active site, 
or if binding of the antibody prohibited the enzyme from binding DNA 
or S-Ado Met. Adams et al (personal communication) have recently 
demonstrated that a pool of four monoclonal antibodies can cross­
link DNA methylase and inhibit enzyme activity by 100Z, while 
the individual monoclonal antibodies reduce enzyme activity by 
less than 50Z. The use of a secondary antibody binding species 
can enhance the precipitation of small immune complexes formed 
between monoclonal antibodies and antigen. Protein A, synthesised 
by Staphylococcus aureus is commonly used in the detection or 
purification of antibodies. This protein binds to the Fc
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region of many IgG molecules with high affinity and specificity. 
Pansorbin, a standardised extract of Staphylococcal protein A has 
proved useful in the detection of polyclonal antibodies against 
DNA methylase.
Although rabbit IgG has a high affinity for protein A, 
the majority of rat immunoglobulins have a much lower affinity 
in comparison (Rousseaux et al, 1981; Nilsson et al, 1982) thus 
limiting its use in the detection of rat monoclonal antibodies. 
Anti-immunoglobulin or protein G (Pharmacia) are likely to prove 
effective substitutes for protein A in the binding and detection 
of rat monoclonal antibody-antigen complexes.
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6.6 Immunoblotting with Monoclonal Antibodies
The problem of detecting denatured antigen with uniform 
affinityJmonoclonaTjantibodies directed against the non-denatured 
protein has been mentioned in Section 6.4. The heterogeneity of 
a polyclonal antibody population is such that small changes in the 
structure of the antigen, such as glycosylation, generally have 
little effect on antibody binding capacity. Even after denaturation 
of the antigen, a proportion of the antigenic determinants remain 
in a sufficiently recognisable state as to be bound and precipitated 
by antibodies (Burnette, 1981). Monoclonal antibodies, however, 
with their single specific recognition site for the antigen, may 
recognise or fail to recognise the denatured protein in an "all- 
or-none" response.
The configuration of proteins following Western transfer 
is speculative; Some proteins may partially renature following SDS 
polyacrylamide gel electrophoresis. A number of studies have shown 
that some GTP-binding proteins can renature following SDS PAGE and 
transfer to nitrocellulose (McGrath et al, 1984, Schmitt et al,
1986, Lapetina and Reep, 1987). During Western transfer, proteins 
may partially regain their native conformation as SDS, migrating 
to the anode, is effectively lost from the sample.
Since an antigenic determinant may be composed of as 
little as four or five amino acids, antibodies directed against 
short stretches of primary protein sequence may still recognise the 
partially denatured antigen. It is possible, therefore, that some 
monoclonal antibodies will detect proteins after Western transfer.
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The lack of reaction of the monoclonal antibodies against 
DNA methylase in immunoblotting experiments again highlights the 
specificity of antibody recognition, and the problems of identifying 
denatured antigen by this procedure. Only six monoclonal antibodies 
have so far been tested in this detection system: It is possible
that on screening of a larger number of the available monoclonal 
antibodies some identity of enzyme determinants will be achieved.
6.7 Immunocytochemical Detection of Antigen
Immunocytochemical techniques may also prove useful in 
localising different forms of DNA methylase present in cells at 
various stages of development.
In terms of both labelling intensity and specificity 
monoclonal antisera react equally as well as polyclonal antisera 
in immunocytochemistry studies, giving cleaner reactions than 
polyclonal antisera with no background staining (Mason et al, 1983). 
Visualisation of specific antibody is achieved by the attachment of 
"labelling" molecules. Commonly used labels include fluorochromes 
such as fluorescein, and enzymes. Specific antibody may be detected 
by the direct binding of the fluorescent label or enzyme to the 
antibody. Alternatively the enzyme may be bound to an intermediate 
such as protein A, or a similar antibody binding molecule. A third 
technique involves the attachment of enzyme to the biotin-avidin 
detection system (Boorsma, 1983). In this system biotin molecules 
are coupled to antibodies, with avidin used as a high affinity
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secondary reagent. The coupling of avidin to fluorochromes or 
enzymes creates an antibody-biotin-avidin-label complex. This 
method has the advantage that secondary antibody is not required.
The use of fluorescent or enzyme conjugated monoclonal 
antibodies should facilitate the precise detection of DNA 
methylase in different cellular fractions, and identify the 
presence or appearance of the enzyme in cells stimulated to 
divide or differentiate.
6.8 Characterisation of DNA Methylase in Mouse
and Other Species
Monoclonal antibodies directed against specific 
epitopes on DNA methylase may be useful in identifying the size 
and distribution of the enzyme in a variety of mouse tissues, 
and, by cross reactivity studies, in the comparison of DNA 
methylases isolated from different species.
Immunoblotting and probing of DNA methylase from mouse
10 5ascites cells with polyclonal antiserum and XAJi protein A has 
identified two bands of purified mouse enzyme of 185-190 kD and 
160 kD. The smaller protein is believed to be a product of 
proteolytic digestion of the 185 kD enzyme (Adams et al, 1988).
In contrast, immunoblotting of DNA methylase isolated from adult 
and newborn mouse liver identifies a single band of 100 kD, 
although some undegraded enzyme may be present in the nucleus 
of newborn mouse liver cells.
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Greater than 802 of DNA methylase activity in newborn 
mouse liver is found tightly bound within the nucleus, as described 
in Section 1.3.1, while only 202 of the total enzyme activity is 
present in this fraction in the adult mouse tissue. A change in 
the distribution pattern of mouse liver DNA methylase, together 
with an increase in degradation of the enzyme occurs as the rate 
of cell division declines with the maturation of liver function 
(Adams et al, 1989). Studies on the distribution of DNA methylase 
in mouse tissues have shown that the 190 kD species is present in 
rapidly growing cells, such as spleen, while the 100 kD species 
of enzyme is found in slower growing tissues such as liver, kidney 
and gut (Adams et al, 1988).
Degradation and redistribution of DNA methylase has also 
been shown to occur in mouse L929 cells entering stationary phase; 
Immunoblotting of enzyme isolated from these cells again detects a 
100 kD species, in comparison with the 190 kD protein identified in 
extracted nuclei and in the nuclear matrix fraction of log phase 
cells (Adams et al, 1988).
The use of monoclonal antibodies to precipitate DNA 
methylase from mouse tissues and cultured cells should give a 
more precise indication of the number of cross reacting species 
of enzyme present in vivo, and also the number of bound proteins.
Interaction of monoclonal antibodies with DNA methylase 
from different species will give an indication of the degree
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of evolutionary conservation not only between mammalian 
methyltransferases but between methyltransferases from a variety 
of vertebrate and invertebrate tissue.
Studies have already shown that polyclonal antiserum 
raised against mouse ascites DNA methylase also interacts with the 
enzyme from many other vertebrates and plants (Adams et al, 1988). 
Mammalian cells generally show protein bands of 180-190 kD with 
some smaller degradation products, similar to the pattern shown 
with the mouse ascites enzyme. Polyclonal antiserum detects a 
200 kD protein in frog spleen, although the major cross-reacting 
proteins in other frog tissues are 135 kD and 148 kD, in agreement 
with the size of the native enzyme detected in Xenopus tissue 
culture cells (Adams, 1981). Protein bands of 140 kD and 120 kD 
have been detected in chick tissues while in pea shoot nuclei the 
presence of a 115 kD protein is indicated.
The use of monoclonal antibodies as probes will 
confirm the indentity of the cross reacting material and will 
allow indentification of antigenic determinants of DNA methylase 
which have been specifically conserved throughout evolution.
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6.9 Studies on MEL Cell Differentiation
As described in Section 1.2.4, mouse erythroleukaemia 
cells (MEL cells) are reported to undergo a genome-wide transient 
demethylation, following the induction of differentiation by agents 
such as DMSO (Razin et al, 1988). The mechanism by which this 
alteration in the 5-mC content of the DNA is effected is unclear.
Bestor and Ingram (1984) have described the presence of 
three similar but distinct forms of DNA methylase in uninduced MEL 
cells, with each species of enzyme associated with a particular 
state of cell proliferation. A 190 kD enzyme was reported in 
rapidly growing cells, a 175 kD protein in late log phase cells 
and a 150 kD enzyme in stationary cells. It is possible that the 
175 kD and 150 kD proteins are the products of degradation of the 
190 kD enzyme found in actively dividing cells. DNA methylase 
activity is very low or absent from non-growing cells and presumably 
the enzyme becomes degraded following cessation of new DNA synthesis.
During induction of differentiation, pre-existing 
DNA methylase may also undergo degradation to a lower molecular 
weight, inactive state, thus perhaps accounting for the transient 
hypomethylation observed in these cells. However, transient 
hypomethylation is observed 12-20 hours after the induction of 
differentiation when a new round of replication is occurring.
It is possible therefore that the observed decrease in methylation 
levels is merely due to the presence of increased levels of newly 
synthesised, unmethylated DNA.
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Using antibodies as probes it should be possible to detect 
any change in the size or distribution of DNA methylase in cells 
undergoing differentiation. This would involve pulse labelling of 
MEL cells with L-[^S]-methionine and subsequent immunoprecipitation 
of DNA methylase from whole cell extracts, nuclei and salt extracted 
nuclei at various intervals between the initiation of induction 
and terminal differentiation. In this way it should be possible 
to determine the half life of the enzyme in differentiating cells 
in comparison with the rate of breakdown of DNA methylase in non­
induced MEL cells.
6.10 Affinity Purification of DNA Methylase
In addition to in vitro and in vivo characterisation 
of DNA methylase, monoclonal antibodies may be the key to 
developing a simpler and more effective purification strategy.
Partially purified DNA methylase has been used to 
methylate SV40 DNA in vitro to determine the effect of methylation 
at specific sites within the promotor region on the binding of 
transcription factors and the transcription of a cloned marker 
gene (Bryans and Adams, 1989, in preparation). To perform these 
and other experiments designed to investigate the role of DNA 
methylation in the control of gene expression, large amounts of 
purified active enzyme are required. The use of an affinity column 
of monoclonal antibodies cross-linked to CNBr Sepharose may provide 
the basis for a rapid and highly effective purification procedure.
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As each monoclonal antibody can bind two molecules of DNA methylase, 
one mole of purified monoclonal antibody should immobilise two 
moles of the enzyme.
Monoclonal antibodies against human placental DNA 
methylase have already been used to affinity purify DNA methylase 
from mouse P815 mastocytoma cells (Pfeifer et al, 1985) achieving 
a 10,000 - 15,000 fold purification over the nuclear homogenate.
DNA methylase has proved to be highly unstable and susceptible 
to degradation during purification, despite the use of protease 
inhibitors at all stages. In addition, low concentrations of 
purified enzyme often prove unstable during storage at -20°C 
despite the presence of 502 (v/v) glycerol and PMSF. The ability 
to specifically concentrate milligram amounts of DNA methylase 
on an affinity column should result in the isolation of highly 
purified enzyme at a suitably stable protein concentration for 
use in in vitro methylation experiments.
Although some considerable difficulties were encountered 
in the use of a polyclonal antibody affinity column, it is hoped 
that a monoclonal affinity column will prove more effective. While 
DNA methylase will be specifically retarded on the column, enzyme 
molecules will be bound at just one point of contact by a single 
antibody molecule. The interacting forces between antibody and 
antigen may therefore be easier to overcome than in the more complex 
situation using a polyclonal affinity column, whereby the enzyme, 
interacting with many antibodies, became irreversibly cross-linked.
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6.11 Limited Proteolysis: An Overview
Limited proteolysis describes the restricted sequential 
peptide bond cleavage in a protein substrate following nucleophilic 
attack by a specific protease. The specificity of proteolytic 
cleavage arises from the close fit required between the substrate 
and the active site of the attacking protease for the successful 
hydrolysis of the peptide bond.
Trypsin is classified as a serine protease, one of a group 
of homologous proteolytic enzymes exhibiting amino acid sequence 
and structural similarities. Particularly, the active sites of the 
serine proteases lie in similar non-polar crevices in each molecule 
(Matthews et al, 1967; Shotton and Watson, 1970; Stroud et al,
1971) and are characterised by a serine residue at position 195 in 
each case. Although trypsin can potentially cleave any lysyl or 
arginyl bond in a protein substrate, limited proteolysis is generally 
expected to primarily affect surface regions of the native protein 
substrate which are readily accessible to the protease, as opposed 
to internal domains of the peptide chain (Naslin et al, 1973).
Limited proteolysis serves as a mechanism for controlling 
many physiological functions in vivo, and the activation of 
enzymes by this means is a feature of several biological systems: 
Trypsin itself is activated from its precursor trypsinogen by 
limited proteolytic cleavage, as are other digestive enzymes 
including pepsin and chymotrypsin. Blood coagulation is controlled 
via a cascade of proteolytic activations of zymogens, including 
prothrombin and fibrinogen, and insulin is proteolytically activated
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from proinsulin. Thus a variety of physiological functions can 
be induced via limited proteolytic cleavage of peptide bonds in 
precursor proteins.
The activity of trypsin and other pancreatic proteases 
is physiologically controlled by specific protease inhibitors.
These proteins are analogues of true trypsin substrates, which have 
evolved in parallel with the enzyme and which bind tightly to the 
active site, through a combination of interactions with specific 
residues and hydrogen bonding (Stroud et al, 1975). The half life 
of the trypsin:trypsin inhibitor complex formed is usually several 
months (Stryer, 1981).
The addition of equimolar amounts of trypsin inhibitor 
to trypsin following limited proteolysis in vitro should therefore 
result in a stable inactivation of the enzyme, with further 
proteolytic action effectively blocked.
6.12 In Vitro Proteolysis of DNA Methylase
Proteolytic digestion of DNA methylase by trypsin is 
thought to result in the sequential hydrolysis of particular peptide 
bonds in the enzyme. The effect of this hydrolysis will presumably 
be, firstly, an increase in the number of peptide chains comprising 
the protein, accompanied by a greater flexibility of reactivity 
between distant functional amino acid residues.
A conformational change in the enzyme structure may be
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responsible for the observed increase in activity of the proteolysed 
enzyme in vitro. Alternatively, the loss of a catalytic regulatory 
domain by proteolytic removal or by spatial distancing from the 
active site following hydrolysis, may result in the methylation of 
hitherto unmethylated sites in DNA; This may involve random CpG 
methylation, or a loss of CpG specificity by the enzyme, with 
ensuing methylation of CpA, CpC and CpT dinucleotides. Evidence 
supporting this latter hypothesis has come from nearest-neighbour 
analysis of DNA de novo methylated with proteolysed enzyme: Results
have indicated that only 432 of methyl groups are added to cytosine 
in the dinucleotide CpG. 242 of cytosines in CpC dinucleotides were 
found to be methylated, as were 202 of cytosines in CpA and 132 of 
cytosines in CpT (Adams et al, 1988).
Trypsin-treated DNA methylase shows a reduced tendency 
to aggregate on incubation, even in the presence of high 
concentrations of DNA, in contrast to untreated mouse ascites 
DNA methylase. Methylation of cloned DNA using untreated enzyme 
declines after several hours incubation, possibly due to enzyme 
aggregation. The proteolysed enzyme shows no such loss of 
activity, and near saturation levels of methylation can be 
achieved (Adams et al, 1988).
The significance of the stimulation in enzyme activity 
observed following limited proteolytic degradation of DNA methylase 
is currently unresolved. It remains possible that the increased 
incorporation of methyl groups in DNA is due to non-specific 
methylation of dinucleotides other than CpG. Such events are not
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unprecedented: Simon et al (1980) have shown a reduced specificity
of the rat liver enzyme for CpG sites, demonstrating that CpA and 
CpT sequences are also methylated. Methylation of cytosine in 
CpA, CpC and CpT in vivo has also been reported by Gruenbaum et al, 
1981; Grafstrom et al, 1985; Nyce et al, 1986; and Sneider, 1980; 
although CpG dinucleotides show the highest level of modifications. 
Further studies on the methylation of DNA using proteolysed and 
unmodified enzyme should resolve this question. An increase in 
the level of in vitro methylation attainable may be possible if 
affinity purification of DNA methylase using monoclonal antibodies 
is successful.
In the event that some loss of specificity is conclusively 
demonstrated, it may be possible to identify a domain of the enzyme 
which normally prohibits non-specific methylations. The binding 
of monoclonal antibodies to such a domain may be found to alter 
the specificity of the enzyme from (predominantly) CpG to CpN.
A further use of in vitro limited proteolysis of DNA 
methylase lies in the identification of the active site of the 
enzyme: N-ethyl-maleimide (NEM) binds S-H groups and has been
shown to inactivate DNA methylase, indicating the presence of an 
S-H group close to the active site (Turnbull and Adams, 1976).
The use of ^C-labelled NEM to bind DNA methylase, following by 
proteolysis and immunoprecipitation of the enzyme-NEM complex 
may reveal the location of the catalytic centre of the molecule.
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6.13 Studies on Mouse Embryo Development
Tissue specific methylation patterns in eukaryotic DNA 
are believed to be established during embryogenesis, when cells 
show evidence of increased levels of de novo methylation (Jahner 
et al, 1982). DNA methylases isolated from various mammalian 
tissues are capable of methylating both unmethylated and hemi- 
methylated DNA substrates, suggesting that one enzyme species is 
capable of performing both de novo and maintenance methylation 
in vivo (Pfeifer, 1983; Grunwald, 1984). The finding that partial 
proteolysis of DNA methylase in vitro often leads to an increase 
in the de novo activity of the enzyme invites the conjecture that 
some form of limited proteolysis may occur in vivo to modulate 
the twin activities. DNA methylase isolated from somatic cells shows 
a preference for hemi-methylated DNA as a substrate. Proteolysis of 
the enzyme may cause an increase in de novo activity by removing a 
domain which normally limits the activity of DNA methylases to hemi- 
methylated sites on DNA. Removal of a domain which recognises 5-mC 
on the parental DNA strand would release the enzyme from the constraint 
of acting only at hemi-methylated sites, leaving it free to methylate 
all available CpG sites. Thus, embryos exhibiting de novo methylation 
activity might be expected to possess a form of the enzyme related to 
that formed by partial proteolysis of the mouse ascites enzyme in vitro.
An immunological approach provides a simple and sensitive 
means for the detection of DNA methylase in embryonic cells. The 
use of specific monoclonal antibodies will reveal the extent of 
cross reactions between the enzyme present in adult somatic cells 
and its embryonic counterpart(s).
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A further in vitro approach is to study the properties 
of DNA methylase in mouse teratocarcinoma cells: F9 cells are
murine embryonal carcinoma cells which can only form derivatives 
of extra embryonic tissue. These cells are capable of de novo 
methylation, demonstrated by the methylation of proviral Moloney 
murine leukaemia DNA made from input M-MuLV RNA (Gautsch and Wilson, 
1983). Isolation of DNA methylase by immunoprecipitation will 
enable a comparison of the size and location of the enzyme present 
in F9 cells with that isolated from rapidly dividing adult mouse 
tissue. The results of these and similar studies with mouse 
erythroleukaemia cells will clarify the importance of DNA methylase 
at different cell cycle stages, and reveal the changes in DNA 
methylase levels as cells undergo differentiation.
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